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ABSTRACT 
Defects in primary cilium biogenesis underlie the ciliopathies, a growing group 
of genetic disorders. We describe a whole genome siRNA-based reverse genetics 
screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a 
global resource for investigation into essential ciliary processes. We identify 112 
candidate ciliogenesis and ciliopathy genes, including 44 components of the 
ubiquitin-proteasome system, 12 G-protein-coupled receptors, and three pre-mRNA 
processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant 
retinitis pigmentosa. The PRPFs localise to the connecting cilium, and PRPF8- and 
PRPF31-mutated cells have ciliary defects. Combining the screen with exome 
sequencing data also identified recessive mutations in two screen candidate genes 
(PIBF1/CEP90 and C21orf2/LRRC76) as causes of the ciliopathies Joubert and Jeune 
syndromes. Affinity proteomics and protein-protein interaction studies place C21orf2 
within key ciliopathy-associated protein modules, offering an explanation for the 
skeletal and retinal involvement observed in individuals with C21orf2-variants. Our 
global, unbiased approaches provide insights into ciliogenesis complexity and 
identify roles for unanticipated pathways in human genetic disease.  
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The primary cilium is a microtubule-based organelle present on the apical surface of 
most vertebrate cells. Primary cilia are regarded as cellular signalling hubs, regulating 
diverse signalling pathways, with particularly important roles during embryonic development 
and the patterning of the developing neural tube1. Defects in primary cilia are associated with 
heterogeneous inherited developmental conditions known as the ciliopathies that often 
present with cystic kidney disease, and other diverse multi-organ phenotypes that affect the 
central nervous system, eye and skeleton2. As a group, ciliopathies are comparatively 
common Mendelian inherited conditions with an overall estimated prevalence of 1 in 20003. 
The importance of the primary cilium has only become apparent in the last decade, 
and therefore processes involved in cilia formation and maintenance remain poorly 
characterised. To address this in the most comprehensive way, we have carried out a high-
throughput cilia characterisation assay to interrogate the involvement of every gene in the 
formation of the primary cilium. This represents a global, hypothesis-neutral approach to 
identify genes involved in ciliogenesis. It also provides a complementary approach to 
traditional linkage analysis, candidate gene, or whole exome sequencing (WES) approaches 
for gene discovery. Previously, several cell-based medium- or small-scale screens of 
ciliogenesis have been published, performed on subsets of target genes such as a druggable 
library (7784 targets)4 and uncharacterised components of the cilia proteome (40 targets)5. 
Here, we present a whole genome knockdown screen in a ciliated cell line that provides a 
comprehensive view of critical factors involved in ciliogenesis and offers numerous candidate 
genes for ciliopathies. 
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RESULTS 
Genome-wide siRNA screen for ciliogenesis 
We used small interfering RNA (siRNA) to knockdown and ascertain the function of 
19059 Entrez RefSeq (B37.1) mouse genes across the genome. The siRNA screen was 
carried out in the mouse inner medullary collecting duct (mIMCD3) ciliated cell-line using a 
Thermo Fisher siGENOME library containing pools of four siRNA duplexes per gene (see 
On-line Methods and Supplementary Note for further details). We assayed for a loss-of-
cilium phenotype 72 hours after transfection by imaging at three focal planes to detect the 
nucleus (DAPI), cytoplasm (TOTO3) and cilium (acetylated Į-tubulin) (Figure 1a). The cilia 
could be identified as single spots above the nucleus of the cell (Figure 1b,c), allowing the 
use of simple cilia recognition protocols based on optimised Perkin-Elmer spot detection 
algorithms (Figure 1b). 
The statistical significance of effects on cilia and cell number after siRNA knockdown 
was tested by calculating robust z scores6 (Figure 1d, Suppl. Table 1). To ensure 
normalisation of data and exclusion of batch-specific effects, data were analysed within 
processed batches (Figure 1e,f). Duplicate assays of batches resulted in little variation, with 
a median Pearson’s correlation coefficient between replicates of 0.71 (Figure 2a), and an 
average strictly standardised mean difference (SSMD) value for all batches of 1.717 (Figure 
1e). Robust z scores for cell number (zcell) and the percentage of cells with a single cilium 
(zcilia) were calculated for all results, compared to the median and median absolute deviation 
(MAD) of all positive and negative controls in a processed batch (Figure 2a,b, Suppl. Table 
1). This allowed application of meaningful statistical cut-off values (zcilia cutoff and zcell cutoff) for 
the identification of significant “hits” affecting ciliogenesis based on the median and MAD of 
positive and negative controls per 10-plate batch7 (Figure 1f). 
 
Filtering strategy, bioinformatics analysis, and validation screens 
In total, 2174 siRNA pools significantly decreased the percentage of cells with a 
single primary cilium (zcilia< zcilia cutoff in a processed batch for both replicates, where zcilia cutoff = 
7 
median z of all positive controls), with 1956 hits targeting a gene with a human orthologue 
(Figure 2c, Suppl. Table 2). We filtered out potential non-specific siRNAs comprising those 
with predicted off-target effects or with microRNA-like effects (see Supplementary Note) 
leaving a total of 1829 mouse genes with a human orthologue (Suppl. Table 2). The list of 
1829 genes was significantly enriched in known ciliary components (the SYSCILIA Gold 
Standard8; p=6.7x10-4 hypergeometric test, observed 48, expected 31.2). Functional 
annotation clustering with enrichment analysis using DAVID9,10 and relevant literature 
information was used to select representative functional candidate hits for further validation 
in a secondary screen. We selected a total of n=40 hits that were components of significantly 
enriched pathways (Figure 2d left panel, Suppl. Table 3) including the spliceosome, the 
proteasome, and the ubiquitin-proteasome system (UPS). 
To exclude the effect of proliferation on ciliogenesis, we filtered the 1829 primary 
screen hits to prioritise those that significantly affected the percentage of cells with a single 
cilium but did not have a significant effect on cell number (zcell>zcell cutoff) in a processing batch 
for both replicates, where zcell cutoff=median z-2MAD for all negative controls; see On-line 
Methods). This filtering gave a total of n=154 hits (Suppl. Table 3) that were significantly 
enriched in known ciliary components (p=7.7x10-4 hypergeometric test, observed 9, expected 
2.5), and were taken forward for validation. DAVID analysis of this list identified enrichment 
of GPCRs, and components of the non-motile primary cilium and the photoreceptor outer 
segment (Figure 2d right panel). In total, 194 functional candidates were taken forward for 
validation in a secondary screen. 
Secondary screening in mIMCD3 cells validated a total of n=68/194 mouse genes 
that had a significant effect on cilia number (zcilia<zcilia cutoff) for n>=1 out of 4 individual siRNAs 
in duplicate, and n=29/194 for n>=2 out of 4 individual siRNAs in duplicate (Table 1, Suppl. 
Table 3). Validated hits included genes identified previously in functional genomics of 
centriole biogenesis in human cells11 including PLK4 and CEP120, and other hits with known 
ciliary roles including CCDC4112 and OFD111,13. PLK4 is implicated in the regulation of both 
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centriole biogenesis and cilia-dependent processes, with mutations causing microcephaly, 
growth failure and retinopathy14,15. In addition, mutations in CEP120 are a cause of the 
skeletal ciliopathy Jeune asphyxiating thoracic dystrophy16, suggesting that our screen has a 
high predictive value to identify genes involved in ciliary processes. Functional classifications 
for a selection of these validated genes are shown in Figure 3a. Interestingly, the two hits 
PRPF8 and PRPF38A have also been implicated in the process of centriolar under-
duplication11. 
Tertiary screening in hTERT-RPE1 cells using pooled siRNAs enabled the 
assessment of increase or decrease in both cilia number and/or cilia length. From the hits 
that were validated by the secondary screen, n=37/68 human genes had defects in cilia 
number and/or length (using conventional cut-offs of z<-2 or z>+2) including: C21orf2, 
CCDC41, OFD1, PIBF1 and PLK4, and several PRPFs (PRPF31, PRPF6 and PRPF8; Table 
1, Suppl. Table 3). Since the tertiary screen validated representative UPS hits (HUWE1 and 
USP39; Table 1, Suppl. Table 3), we used hTERT-RPE1 cells and individual siRNAs in a 
secondary screen to investigate all enriched human UPS components from the primary 
screen (n=57/1829). This validated a total of n=44/57 genes that had a significant effect on 
cilia number and/or cilia length (using cut-offs of z<-2 or z>+2) for n>=2 out of 3 individual 
duplexes (Suppl. Table 4; see Supplementary Note for further details). Interestingly, out of 
the 24 proteasome subunits represented in this secondary screen, knockdown of the majority 
(n=17/24) caused a significant increase in cilia number (Suppl. Table 4). 
 
Validation screens identify PRPFs and GPCRs as components of ciliogenesis 
pathways 
Based on our significance analyses, functional categorisation, relevant literature 
information, and availability of validated reagents, we chose a total of 15 genes encoding 
GPCRs, PRPFs, and predicted centrosomal proteins for further study. For each gene we 
measured a reduction in mRNA levels by quantitative PCR (Figure 3b), and, when possible, 
decrease in protein levels by western immunoblot analysis (Figure 3c). We confirmed the 
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decrease in cilia number was accompanied by a reduction in immunostaining of the knocked-
down protein by immuofluoresence (IF) microscopy (Figure 3d, Suppl. Figure 1a). 3D 
spheroid culture of mIMCD3 cells was also used as a more physiologically relevant model to 
confirm the effect of Plk4 knockdown on cilia number (Figure 3e). 
PRPFs were selected for further analysis since PRPF6, PRPF8 and PRPF31 are all 
mutated in autosomal dominant retinitis pigmentosa (RP types 60, 13 and 11, respectively). 
The pathogenic mechanism for these forms of RP remains poorly understood, and none 
have been characterised as non-syndromic retinal ciliopathies. Although PRPF6, PRPF8 and 
PRPF31 predominantly localised to the nuclear speckles as expected (Figure 3d, 4a-c), we 
also detected co-localisation of these proteins to the base of the cilium in diverse human and 
mouse ciliated cell-lines (Figure 4a) and to the cilium of photoreceptor cells in adult mouse 
retina (Figure 4b). Immunoelectron microscopy staining showed that PRPF6 and PRPF8 
localised to the apical inner segment, basal body complex, apical connecting cilium of 
photoreceptor cells (Figure 4d) and post synapse of secondary retinal neurons (data not 
shown). 
We obtained adult dermal fibroblasts from three RP11 families carrying the 
heterozygous PRPF31 frame-shift mutation c.1115_1125del17. Fibroblast lines from 
individuals either mildly or severely affected with RP had statistically significant decreases in 
the length and/or number of cilia, compared to an age-matched disease-control individual 
with age-related macular degeneration (ARMD) and healthy control individuals (Figure 4e). 
Furthermore, a Caenorhabditis elegans strain (MR247; see On-line Methods) containing a 
homozygous splice-site mutation (rr40) in the PRPF8 orthologue (prp-8) previously 
associated with reduced spliceosome function in the germline18, had a partial ciliogenesis 
defect (Figure 4f). The microtubule singlet (A-tubule)-containing distal segments (DS) of at 
least 4 (of 10) amphid channel sensory cilia were truncated or missing entirely, and in those 
distal segments that remained, A-tubule numbers were abnormally low (Figure 4f). A few 
axonemes in the distal segment/middle segment (MS; microtubule doublets) boundary also 
had reduced microtubule numbers (Figure 4f). 
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Many of the human GPCRs identified as hits in our validation screen were 
neuroactive GPCRs. We therefore investigated the localisation of these proteins in a human 
ciliated neuroblastoma cell-line (SH-SY5Y) with neuronal-like characteristics that differentiate 
by extending neurites. We identified the localisation of most of these GPCRs (HTR1B, 
P2RY14, MAS1, OPRL1, and CRHR2) to the base of the cilium in differentiated SH-SY5Y 
cells (Figure 5a, Suppl. Figure 1a) and to the ciliary region of photoreceptors of murine 
retinas (Figure 5b). Higher resolution fluorescence and immunoelectron microscopy of a 
sub-set revealed localisation at the basal body and adjacent centriole of the connecting 
cilium, at the apical part of the connecting cilium (outer segment base), and in the axoneme 
of the outer segment of photoreceptor cells (Figure 5c,d). We confirmed the localisation of 
several GPCRs (SREB3, MAS1, P2RY14 and CRHR2) to the base of primary cilia in the 
marginal zone (layer I), sub-plate zone (layer IV) and ventricular zone (layer VI) of embryonic 
mouse neocortex (Suppl. Figure 1b). In knock-out mouse embryos mutated for the transition 
zone orphan receptor TMEM67 (meckelin)19, the ciliary localisation of these GPCRs was lost 
(Suppl. Figure 1b) suggesting that they require the structural or functional integrity of the 
transition zone to maintain their ciliary localisation. We hypothesised that ligand binding to 
GPCRs may promote the earliest stages of ciliogenesis. However, treatment of proliferating 
mIMCD3 cells and hTERT-RPE1 cells with a range of concentrations of antagonists against 
CRHR2, HTR1B and OPRL1 over 6-72 hours had no effect on ciliogenesis (data not shown). 
Inhibition of ligand binding was therefore not sufficient to inhibit cilia formation, suggesting 
that other mechanisms regulate ciliogenesis through GPCRs e.g. endocytic membrane 
trafficking20. 
 
Validated screen hits PIBF1 and C21orf2 predict new ciliopathy disease genes for 
Joubert syndrome and Jeune syndrome 
We next investigated whether our list of validated ciliogenesis effectors could be used 
to prioritise predicted pathogenic variants identified from WES of ciliopathy patients including 
Joubert syndrome and Jeune syndrome. Joubert syndrome (JBTS; OMIM #213300) 
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represents a classic ciliopathy characterised by hypotonia, ataxia, cognitive impairment, and 
a distinctive brain malformation (the so-called “molar tooth sign”), with retinal dystrophy, 
cystic kidney disease, liver fibrosis and polydactyly occurring in subsets of patients21. Jeune 
asphyxiating thoracic dystrophy (JATD; Jeune syndrome, OMIM #611263) is a 
chondrodysplasia within the short-rib polydactyly syndrome ciliopathy spectrum, 
characterised by shortened limbs and ribs and a narrowed chest. Additional features include 
polydactyly, kidney cysts and renal failure, retinal degeneration and liver disease22. 
A rare, homozygous missense variant (NM_006346.2: c.1910A>C, p.Asp637Ala) in 
PIBF1 (also known as C13orf24 or CEP90) was identified by WES in an affected JBTS 
individual of Schmiedeleut Hutterite descent (H1-3) and a similarly affected brother (H1-4; 
Figure 6a-c, Suppl. Figure 2a-c, Suppl. Table 5), in the absence of pathogenic mutations 
in known JBTS genes (Suppl. Table 5). The c.1910A>C variant segregated with the 
phenotype (Suppl. Figure 2b), was absent in the Exome Variant Server (EVS) and Exome 
Aggregation Consortium (ExAC) datasets, and was identified as homozygous in the affected 
individuals from a further three Hutterite families (H2, H3 and H4; Suppl. Figure 2b) 
suggesting a founder effect. Imaging findings for PIBF1-mutated individuals ranged from the 
classic molar tooth sign to moderate vermis hypoplasia with mildly thick superior cerebellar 
peduncles and characteristic superior cerebellar dysplasia (Figure 6a-c, Suppl. Figure 3, 
Suppl. Table 6). All individuals for whom information was available had ataxia and 
developmental delay, ranging from mild to moderate (Suppl. Table 7). Targeted molecular 
inversion probe sequencing (MIPS) of known JBTS genes and WES (Suppl. Table 5) 
identified a further seven families in which the affected individuals carried heterozygous 
truncating PIBF1 variants (out of 643 additional families sequenced) in the absence of 
pathogenic mutations in known JBTS genes. Although exogenous expression of human wild-
type PIBF1 rescued ciliogenesis in mIMCD3 cells following siRNA knockdown of 
endogenous Pibf1, expression of PIBF1 containing the p.Asp637Ala Hutterite variant was 
unable to rescue normal ciliogenesis suggesting that it is a pathogenic missense mutation 
(Suppl. Figure 4). 
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We next cross-compared WES data from patients with JATD to validate ciliogenesis 
candidate genes from the screen. Compound heterozygous missense changes in C21orf2 
(NM_004928.2: c.218G>C, p.Arg73Pro and c.671T>C, p.Leu224Pro) were identified in two 
affected siblings of non-consanguineous Caucasian northern European descent (UCL-111.1 
and UCL111.2; Suppl. Table 5, Suppl. Figure 5a) with a clinical diagnosis of JATD. 
Compound heterozygous mutations (p.Leu161Serfs*9 and predicted intronic splice site 
mutation c.96+6T>A) were also found in a non-consanguineous Caucasian northern 
European individual UCL78.1 (Suppl. Table 7, Suppl. Figure 5f). All variants were either 
very rare or absent from the EVS and ExAC datasets, predicted damaging by Polyphen2 
and/or Mutationtaster, and/or were non-conservative changes in highly conserved regions 
(see On-line Methods for further details). The three affected individuals presented with 
narrow thorax (Figure 6d-g,i,j, Suppl. Table 7) and pelvic bone malformation (Figure 6h) in 
skeletal radiological surveys. All developed retinal degeneration due to cone-rod dystrophy in 
childhood but none had impairment of renal function (Figure 6k,l, Suppl. Table 7). Further 
screening of C21orf2 identified a homozygous missense change shared with the UCL-111 
family (p.Arg73Pro) in individual GC4693.1 and four siblings, all of whom have cone-rod 
dystrophy, severe scoliosis and hip dysplasia (Suppl. Figure 5b, Suppl. Table 7). Sanger 
sequencing confirmed that all variants segregate with the disease (Suppl. Figure 5a-f). 
Exogenous expression of both the p.Arg73Pro and p.Leu224Pro variants in C21orf2 partially 
rescued ciliogenesis in mIMCD3 cells following siRNA knockdown of endogenous C21orf2, 
suggesting that they are hypomorphic mutations (Suppl. Figure 4). 
Homozygous mutations in C21orf2 were also found in patients that initially presented 
with isolated cone-rod dystrophy (Figure 6l), consistent with a previous report that C21orf2 is 
mutated in non-syndromic retinal degeneration23. Re-assessment of these individuals 
revealed previously unidentified skeletal involvement in CR-F024.1 (c.103delA, 
p.Ile35Phefs*10; Figure 6I,j, Suppl. Table 7, Suppl. Figure 5c). These findings indicate that 
mutations in C21orf2 (Figure 6m) cause both syndromic and non-syndromic forms of retinal 
dystrophy, with a variable spectrum of skeletal involvement. 
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The validated screen hit C21orf2 forms a ciliary functional module with NEK1 and 
SPATA7 
C21orf2 (also known as LRRC76) is an LRR-containing protein conserved from C. 
elegans to human (Figure 6m). Although a small-scale siRNA screen suggested that 
knockdown impairs ciliogenesis and Hedgehog (Hh) signalling in mammalian cell cultures5, 
the exact role of this protein in ciliogenesis is unclear. C21orf2 localises to the basal body in 
mIMCD3 and hTERT-RPE1 cells and to the base of the connecting cilium in mouse 
photoreceptors (Figure 3d, Suppl. Figure 6a). Immunostaining confirms expression in 
tissues consistent with the phenotype of JATD, including developing ribs and hip joint in 
mouse embryos (Suppl. Figure 6b). Tandem affinity purification followed by mass 
spectrometry (MS) analysis identified a total of 88 unique proteins co-purifying with Strep-tag 
II/FLAG (SF-TAP) tagged C21orf2 in n2/3 experiments (Suppl. Table 8). Affinity proteomics 
(Figure 7a) and co-immunoprecipitation assays (Figure 7b,c) revealed that C21orf2, NEK1, 
and a retinal ciliopathy protein, SPATA724, are part of the same protein complex. 
Furthermore, co-immunoprecipitations with anti-NEK1 (Suppl. Figure 7a) followed by MS 
analysis of unique peptides (for three concurrent repeats of the experiment) showed that 
NEK1 pulled down endogenous C21orf2 from bovine retinal lysates (Suppl. Table 9). 
Immunofluorescence studies showed that C21orf2 co-localises with NEK1 and SPATA7 at 
the basal body in hTERT-RPE1 cells (Suppl. Figure 6c), and GST pull-down of SPATA7 
from bovine retinal lysates efficiently recovered endogenous C21orf2 and NEK1 (Suppl. 
Figure 7b, Suppl. Table 9). Collectively, these data indicate the existence of a ciliary 
functional module that includes NEK1-C21orf2-SPATA7, which occurs endogenously in 
ciliated cells (Suppl. Table 9). Importantly, both the p.Arg73Pro and p.Leu224Pro mutations 
in C21orf2 abolished the interaction with NEK1 (Figure 7c). 
The association of C21orf2 with NEK1 could provide an explanation for the variable 
JATD skeletal phenotype observed in C21orf2-mutated individuals (Figure 6d-j), since 
mutations in NEK1 cause short-rib polydactyly syndrome type II (SRPS type II; Majewski 
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syndrome, OMIM #263520) in humans25, a ciliary chondrodysplasia related to JATD. 
Furthermore, the association of C21orf2 with SPATA7 could explain the prominent retinal 
phenotype (which tends to be only an occasional feature of typical JATD) in individuals with 
C21orf2 mutations, since mutations in SPATA7 cause the retinal dystrophies Leber 
congenital amaurosis type 3 (LCA3) and juvenile RP (OMIM #604232). Knockdown of nek1 
in zebrafish using antisense morpholino oligonucleotides (MO; verified in Suppl. Figure 7c) 
produced classical ciliopathy phenotypes, with a ventrally curved body axis, hydrocephalus, 
otolith abnormalities and abnormal craniofacial cartilage development (Figure 7d). 
Knockdown of nek1 also resulted in retinal defects including loss of photoreceptors (Suppl. 
Figure 7fd-g) and cilia length defects in the pronephros (Suppl. Figure 7h,i). Co-injection of 
human wild-type (WT) C21orf2 RNA with the nek1 MO partially rescued these phenotypes 
(Figure 7e), consistent with the functional interaction between C21orf2 and NEK1. RNA 
expressing C21orf2 with the missense mutation p.Arg73Pro rescued the nek1 morphant 
phenotype less effectively than wild-type, whereas C21orf2-p.Leu224Pro had little effect 
(Figure 7e), confirming the predicted hypomorphic effect of both variants observed in vitro 
(Suppl. Figure 4). 
 
DISCUSSION 
Here we present a whole genome siRNA-based functional genomics screen to 
identify genes whose activity is required for ciliogenesis and/or cilia maintenance. By 
interrogating every gene for a role in these processes, we obtained a global resource for 
investigation and interventions into the processes that are critical for the ciliary system. Our 
visual assay was primarily designed to test the presence or absence of cilia in the primary 
screen, and we provide all numerical features for this cellular phenotype as a functional 
resource to investigate aspects of cilia biology (Suppl. Table 1). In addition, we also imaged 
other cellular phenotypes during data acquisition (cilia intensity and nuclear morphology) and 
include these other numerical features (Suppl. Table 1) to enable the scientific community to 
interrogate and further annotate our screen data-set. 
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To minimise the false positive rate, we extensively characterised a widely used 
cellular model system (ciliated mIMCD3 cells) by arrayCGH, and our siRNA library was 
filtered for off-target effects, partial on-target effects and microRNA-like effects (Figure 2c, 
Suppl. Table 1). Using stringent filters and robust statistical cut-offs, we identified 194 genes 
which significantly affected ciliogenesis and were of particular functional interest, and took 
these on for validation by further knock down experiments in mIMCD3 and hTERT-RPE1 
cells. 
In total, we present a high confidence list of 68 validated genes that play significant 
roles in ciliogenesis in mIMCD3 cells, of which 37 were further found to affect ciliogenesis in 
hTERT-RPE1 cells (Table 1, Suppl. Table 3). A parallel secondary screen validated a 
further 44 genes encoding components of the UPS (Suppl. Table 4). Validated hits include 
CEP120, KCNQ1, several GPCRs (CRHR2, HTR1B and OPRL1) and PRPFs (PRPF6, 
PRPF8, PRPF31 and PRPF38A) (Figure 3a-b, Table 1, Suppl. Table 3). The specificity of 
the screen for targeting mediators of ciliogenesis is demonstrated by the number of genes 
that have been independently implicated in this process. These include CCDC4112, OFD113, 
CEP12016 and PIBF126. C21orf2 has been suggested to have a role in ciliogenesis from a 
previous small-scale siRNA screen5. In a complementary functional genomics study, PLK4, 
CEP120, PRPF8 and PRPF38A have all been implicated in the process of centriolar under-
duplication11. Furthermore, PLK4, OFD1, CDC27, PRPF6 and PRPF8 were identified in the 
Mitocheck screen as important effectors of cell division27. Shared hits across multiple 
independent functional genomics studies indicate that our screen is a useful resource for the 
identification of proteins and functional modules that are essential for cilia biology and related 
cell biological processes. 
This study also demonstrated the power of an unbiased screen to discover  cellular or 
molecular processes that play a role in cilium biology. To illustrate this point, our screen 
unveiled neuroactive GPCRs as one of the functionally enriched groups of proteins affecting 
ciliogenesis (Figure 3a, Table 1, Suppl. Figure 1). GPCRs may play sensory or signalling 
roles in the ciliary vesicle or procilium at the earliest stages of ciliogenesis both in the 
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developing brain and in other tissues28. In support of this hypothesis, adenylyl cyclase III co-
localises with GPCRs at proximal ciliary regions in the developing neocortex, and over-
expression of specific ciliary GPCRs, including the 5-HT6 serotonin receptor, in cortical 
neurons causes cilia elongation29. 
Although the role of the PRPFs in the spliceosome is well-known and well-studied, we 
identified a group of seven splicing factors including PRPF6, PRPF8, PRPF31 and PRPF38a 
(Table 1) that are required for ciliogenesis. We demonstrate that PRPFs mutated in retinitis 
pigmentosa localise specifically to the base of the primary cilium in several different cell-
types (Figure 3d, Figure 4a) and to the basal body complex and connecting cilium in 
photoreceptors (Figure 4b,d). We speculate that some of the splicing factors fulfil an 
additional ciliary function independent of their nuclear role in splicing. In support of this notion, 
two previous studies of the centrosomal proteome have suggested that splicing factors, 
including two of the splicing factors identified in our screen (PRPF6 and PRPF8), may be 
true centrosomal proteins30,31. However, it seems less speculative to hypothesise that these 
proteins may be required for the correct splicing of an unidentified subset of genes that are 
involved in cilia formation. In support of the possible involvement of pre-mRNA processing 
factors in ciliogenesis, previous screens have identified that several splicing factor hits are 
important in related cellular processes of microtubule formation and regulation, namely 
centriolar biogenesis (PRPF8, PRPF38A)11 and cell division (PRPF6, PRPF8)27. 
Several hits in our screen have a known function in the ubiquitin proteasome system 
(UPS), reflecting an importance of specific proteostasis mechanisms in mediating or 
regulating ciliogenesis which could be mediated through, for example, ubiquitination or 
SUMOylation of ciliary transcription factors or chaperoning of ciliary proteins to the base of 
the cilium. Remarkably, 5/7 of our splicing factor hits (LSM2, PRPF6, PRPF8, PRPF31 and 
USP39) are implicated in the ubiquitin-dependent regulation of the spliceosome32. It is 
interesting to note that the interaction of PRPF8 with ubiquitinated PRPF3 is regulated by the 
deubiquitinating enzyme USP4, and that loss of USP4 prevents the correct splicing of 
mRNAs including those for Į-tubulin32. In support of this mechanism, we observe that a 
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viable C. elegans strain possessing a splice site mutation in PRPF8/prp-8 has structural and 
numerical defects of axonemal microtubules in the primary cilia of amphid sensory neurons 
(Figure 4f). Thus, UPS and/or PRPF proteins could act as multifunctional “nexus molecules” 
that are involved in multiple aspects of proteostasis of ciliary proteins or their trafficking (for 
example, the ubiquitin-mediated internalisation and endosomal sorting of GPCRs). 
Alternatively, or additionally, these specific PRPFs could also ensure the correct splicing of 
transcripts encoding proteins important for ciliogenesis, including structural components of 
the cilium such as Į-tubulin32,33. 
We also show the specificity and clinical utility of the screen as a tool for disease-
gene discovery. When combined with large variant datasets, for example WES of ciliopathy 
patients, the functional data from our siRNA screen allowed the filtering and prioritisation of 
variants to identify pathogenic mutations. Although previous studies have indicated both 
PIBF1 and C21orf2 as functional candidate genes for ciliopathies5,23, we formally 
demonstrate the utility and validity of a systems biology approach by the identification of 
mutations in these genes in JBTS and JATD patients, respectively (Figure 6, Suppl. Table 
7). Furthermore, our affinity proteomics data provides an explanation of the mechanism for 
the variable phenotype in this form of JATD. We propose that the retinal phenotype observed 
in C21orf2-mutated patients may result from a dysfunctional SPATA7-C21orf2-containing 
module in the photoreceptors of these patients. Conversely, the skeletal phenotype observed 
in both C21orf2- and NEK1-mutated human patients probably has a common origin in the 
disruption of the C21orf2-NEK1 interaction. NEK1 is a serine-threonine kinase and two 
serines (positions 136 and 177) in C21orf2 have been previously found to be 
phosphorylated34. In light of this, our affinity proteomics findings, and the incomplete rescue 
of NEK1 knockdown effects in zebrafish by C21orf2 overexpression, C21orf2 might represent 
a substrate of NEK1. 
In conclusion, our findings highlight the utility of combining different systems biology 
approaches, namely high-content functional genomic screening, WES, and affinity 
proteomics. Our approach has identified ciliary roles for well-studied proteins, identified 
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disease-causing genes, allowed the refinement of patient phenotypes, and highlighted 
potential disease pathways that could provide deeper insights into cilium biology. This work 
demonstrates the utility of a systems biology approach in providing a compendium of 
candidate genes and offering insights into pathogenic mechanisms for an increasingly 
important group of Mendelian conditions, the ciliopathies. 
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Accession numbers: PIBF1: NM_006346.2 and NP_006337.2; C21orf2: NM_004928.2 and 
NP_004919.1. Whole exome sequencing data is available from the UK10k Consortium 
(UK10kCIL5236549 and UK10kCIL5236550) and dbGaP (phs000205.v5.p2) 
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FIGURE LEGENDS 
Figure 1. Automated high content imaging, validation of siRNA screen controls and 
calculation of cut-off values. (a) Schematic of a polarised mIMCD3 cell showing the focal 
planes used to image nuclei (blue), cytoplasm (pink) and ciliary axonemes (green). (b) 
mIMCD3 cells imaged using an Operetta high-content imaging system, with representative 
images from Harmony/Columbus software of cilia recognition (“find spots”). Scale bar = 10 
ȝm. (c) Upper panels: significant effect on ciliogenesis following reverse transfection with 
positive control siRNA pool against Ift88 compared to non-targeting scrambled siRNA, 
imaged by immunostaining for acetylated (Ac) Į-tubulin (green). Bar graph (green) 
quantitates the effect on ciliogenesis (% cells with a single cilium) for positive controls (Plk1, 
Mks1, Rpgrip1l, Ift88) and negative (-ve) controls including MLNR, scrambled (scr.) siRNAs 
and mock transfection. Lower panels: positive transfection control siRNA pool against Plk1 
has a significant effect on cell number. Images show cells stained for acetylated Į-tubulin 
(green), TOTO3 (pink) and DAPI (blue). Bar graph (blue) quantitates the effect on cell 
number following knock-down with control siRNAs. Scale bar = 20 ȝm. Significance of 
pairwise comparisons with all negative controls (#): ns, not significant; * p<0.05, ** p<0.01, 
*** p<0.001, **** p<0.0001 (paired two-tailed Student’s t-test), for n=32 independent 
replicates. (d) Bar graphs showing mean robust z score for % cells with a single cilium (zcilia) 
and mean robust z scores for cell number (zcell) for positive and negative siRNA controls. (e) 
Strictly standardised mean difference (SSMD) values for each replicate per batch in the 
screen. The average SSMD value for all batches was 1.717. Each bar is colour-coded by 
batch for sub-libraries in the ThermoFisher mouse siGENOME library (m, mouse; GPCR, G 
protein-coupled receptor; UC, ubiquitin conjugation; IC, ion channel; PP, protein 
phosphatase; P, protease; PK, protein kinase) or set of 10 plates (DT, druggable targets; G, 
genome libraries). (f) Robust z score cut-off values for cilia number (zcilia cutoff) calculated for 
each replicate per batch with error bars indicating median absolute deviation, where zcilia cutoff 
is the median z score for all positive controls. Dots are colour-coded by batch for sub-
libraries as in (e). 
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Figure 2. Analysis and data filtering strategy for the whole genome siRNA screen. (a) 
Scatter plot of zcilia values of two screen replicates (rep. 1 and rep. 2). Each dot represents 
one targeted gene in the Thermo Fisher mouse siGENOME library, colour-coded by batch for 
either sub-library (m, mouse; GPCR, G protein-coupled receptor; UC, ubiquitin conjugation; 
IC, ion channel; PP, protein phosphatase; P, protease; PK, protein kinase) or set of 10 plates 
(DT, druggable targets; G, genome libraries). The median Pearson’s correlation coefficient 
(R2) between replicates was 0.71, if failed measurements in batch mDT51-60 were excluded 
(grey region). (b) Scatter plot of mean zcilia values plotted against robust z scores for cell 
number (zcell) for each targeted gene in the screen with each batch colour-coded as for (a); 
candidate hit genes are indicated. (c) Schematic to summarise data filtering steps in the 
primary, secondary and tertiary screens (complete datasets shown in Suppl. Tables 1-3, 
respectively). The number of genes filtered at each step are shown in bold, with the filter 
applied highlighted in grey boxes (see main text and On-line Methods for further details). 
Validated hits are listed in Table 1. (d) Classification enrichment for selected GO terms, or 
KEGG and BioCarta pathways/processes as determined using DAVID. Left bar graph: 
n=1829 screen hits with a significant effect on cilia number (zcilia< zcilia cutoff), without filtering 
for any effect on cell number, that had a human homologue. Right bar graph: 154 filtered 
screen hits with a human homologue that showed a significant effect on cilia number (zcilia< 
zcilia cutoff) but no significant effect on cell number (zcell> zcell cutoff), where zcell cutoff is the median z 
- 2MAD of all negative controls. The significance for terms or pathways was determined by a 
Benjamini-Hochberg q threshold value <0.05 (red dotted line) to correct for the false 
discovery rate, with the number of associated human genes shown above each bar. 
 
Figure 3. Validation screens of ciliogenesis genes. (a) Robust z scores for % cells with a 
single cilium (zcilia) for selected validated genes from the secondary screen, each assayed in 
two replicates with four individual siRNAs in mouse mIMCD3 cells. Error bars indicate the 
range in values for the replicates. Cut-off value of zcilia cutoff = -1.34 is indicated (red dotted 
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line), calculated as the median z of positive controls. Colours indicate selected functional 
annotations. (b) Bar graphs for quantitative PCR values for knock-down of the indicated 
target genes, for all assays when negative control (siScr.) cycle threshold (Ct) values<30. 
Transcript levels expressed as relative quantities, with the statistical significance of the 
indicted pair-wise comparisons: * p<0.05, ** p<0.01 and **** p<0.0001 (unpaired two-tailed 
Student’s t-test), for n=3 independent replicates. Error bars indicate s.d. (c) Western 
immunoblots (IB) showing knockdown of expression for the indicated proteins. Loading 
control is ȕ-actin (act.), with the ratio of band intensities shown below. (d) IF confocal 
microscopy of mIMCD3 cells knocked-down with siRNAs for the indicated validated genes 
from the screen and immunostained for the cognate protein (green) and acetylated (Ac) Į-
tubulin (red). Magnified insets for selected cells (white arrowheads) are shown in white 
frames. All knockdowns cause loss of ciliary-associated protein (yellow arrowheads) and cilia. 
Scale bars = 10ȝm. (e) Knock-down of Plk4 in three-dimensional spheroid cultures of 
mIMCD3 cells causes statistically significant ciliogenesis defects (visualised by acetylated 
(Ac) Į-tubulin in white); ** p<0.01 (paired two-tailed Student’s t-test), for n=3 independent 
experiments. The number of cells analysed were control: 204, 195 and 190; and Plk4 
knockdown: 198, 106 and 212, respectively, for each experiment. Error bars indicate s.d. 
Scale bars = 10ȝm. 
 
Figure 4. Ciliary localisation and functional effect on ciliary axonemal formation of pre-
mRNA processing factors. (a) PRPF6, PRPF8 and PRPF31 (green) localise to 
proximal/basal regions of primary cilia (green arrowheads) and nuclear speckles in the 
indicated cell-lines. Selected cells (white arrowheads) are magnified (insets). (b) PRPF6, 
PRPF8 and PRPF31 (green) localise to the ciliary regions of photoreceptor cells (connecting 
cilium, CC) and nuclei of inner nuclear layer (INL) in longitudinal sections of adult murine 
retinas. Retinal layers are depicted schematically: photoreceptor outer segment (OS), 
connecting cilium (CC), and inner segment (IS); secondary neurons (2nd); ganglion cell layer 
(GC); synaptic region (S) in the outer and inner plexiform layer (OPL and IPL). (c) 
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Immunoelectron microscopy confirms localisation of PRPF6 and PRPF8 in nuclear speckles 
in the INL (arrowheads). Frames indicate the magnified insets. (d) Immunofluorescence of 
PRPFs (green) and the ciliary marker centrin-3 (red), and immunoelectron microscopy, 
reveal localisation of PRPF6 and PRPF8 at the basal body (BB) and adjacent centriole (CE) 
of the CC (arrowheads) and apical CC (arrow). (e) Primary cilia length and number 
measurements for dermal fibroblasts from normal healthy controls, age-matched disease-
control (ARMD), and four patients with RP type 11 of variable severity carrying heterozygous 
(+/-) PRPF31 frame-shift mutation c.1115_1125delGAAGCAGGCCA. Significance of pair-
wise comparisons with the disease negative control (#): ns, not significant; * p<0.05, *** 
p<0.001, **** p<0.0001 (paired two-tailed Student’s t-test), for n=4 independent experiments. 
Error bars indicate s.d. (f) Transmission EM images of sensory cilia from sequential cross 
sections (numbered arrows in schematics) of C. elegans amphid pore in wild-type (N2) and 
prp-8(rr40) mutants. Wild-type amphid pores contain 10 ciliary axonemes, each consisting of 
a distal segment (DS; singlet A microtubules), middle segment (MS; doublet A/B 
microtubules), transition zone (TZ) and periciliary membrane compartment (PCMC). In prp-
8(rr40) mutants, axonemes are missing in DS and DS/MS boundary, and microtubule (MT) 
number is reduced. Images are representative of four analysed amphid pores for each strain. 
Scale bars: (a) 20 µm and 5 µm; (b) 50 µm; (c) 800 nm; (d) 1 µm and 0.4 µm; (f) 200 nm (low 
magnification images), 100 nm (high magnification images). 
 
Figure 5. Ciliary localisation of G protein-coupled receptors. (a) Localisation of selected 
indicated GPCRs (green) to proximal or basal regions of primary cilia (polyglutamylated Į-
tubulin; red) in differentiated SH-SY5Y neuronal cells. Magnified insets for selected cells 
(white arrowheads) are shown in white frames. Scale bar = 10ȝm. (b) Immunofluorescence 
(IF) labelling of MAS1 and OPRL1 (green) in the ciliary regions of photoreceptor cells (CR) 
(red; yellow arrowheads in magnified insets) in adult mouse retina. Abbreviations: GCL, 
ganglion cell layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear 
layer. Scale bar = 50ȝm (c) High magnification immunofluorescence for GPCRs (green) and 
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centrin-3 (red) reveals localisation of GPR20, SREB3, and MAS1 at the adjacent centriole 
and the basal body (arrowheads) of the connecting cilium. Scale bars = 1ȝm (d) IEM reveals 
SREB3, MAS1, and HTR1B at the basal body (BB) of the connecting cilium (CC) 
(arrowheads). Immunoelectron microscopy of MAS1 shows additional labelling throughout 
the CC and at the ciliary tip (arrow; two different images of photoreceptors are merged at the 
dashed line). Abbreviations: CE, centriole; IS, inner segment; OS, outer segment. Scale bars 
= 400nm.  
 
Figure 6. Clinical features of ciliopathy patients with mutations in validated hits PIBF1 
or C21orf2. (a-c) Brain MRI findings for PIBF1-related Joubert syndrome in individual H1-4. 
Molar tooth sign with moderate vermis hypoplasia, elevated and thickened superior 
cerebellar peduncles (arrowhead), and superior cerebellar dysplasia (arrow) indicated. (a) is 
a T1-weighted and (b-c) are T2-weighted images. (d-l) Clinical features of individuals with 
C21orf2 mutations including narrow and deformed thorax in UCL 78.1 (d-f; child), UCL-111.1 
(g; child) and CR-F024.1 (i-j; adult). UCL78.1 presented with a slightly dysplastic pelvis (h) in 
later childhood. Examples of fundoscopy images revealing mild pigmentary depositions and 
some mottling shown for CR-F024.1 (k) and 111.2 (l); both patients were clinically blind at 
the time of examination. (m) Upper panel: schematic of the PIBF1 protein (NP_006337.2) 
showing the approximate positions of coiled coil domains (green boxes) and the p.Asp637Ala 
mutation. Lower panel: schematic of the C21orf2 protein (NP_004919.1) showing the 
positions of three leucine-rich repeats (LRR1-3, blue boxes), an LRRCT motif occurring C-
terminal to LRRs (green box) and mutations. 
 
Figure 7. Validated hit C21orf2 forms a ciliary functional module with NEK1 and 
SPATA7. (a) Interactions between C21orf2, NEK1 and SPATA7 were identified by tandem 
affinity purification. The values indicate sequence coverage of identified prey peptides 
(horizontal) co-purified with specific bait proteins (vertical); see Suppl. Table 8 for details. (b) 
Reciprocal coimmunoprecipitation of HA-C21orf2 and both NTAP-NEK1, and NTAP-SPATA7 
(5% input: panels 1 and 2; immunoprecipitation (IP) assays in panels 3 to 6), but not the 
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negative control HA-LRRK2 (LRR; panels 4 and 6: lanes 2 and 4) following immunoblot (IB) 
detection of either the HA or FLAG (Strep-tag II-FLAG, NTAP) epitopes. (c) FLAG-NEK1 
coimmunoprecipitates wild-type (WT) C21orf2 (panel 4, lane 1; indicated by arrow), but not 
p.Arg73Pro or p.Leu224Pro mutant C21orf2 (panel 4, lanes 2 & 3) or the negative control 
HA-LRRK2 (LRR; lanes 4 to 6). Positive control co-IP (NPHP4-RPGRIP1L) is in lane 7, 10% 
input is shown in panels 1 and 2 and IP assays in panels 3 to 6. IgG heavy chain (HC) is 
indicated in panel 4. (d) Antisense morpholino oligonucleotide (MO1) injection against 
zebrafish nek1 resulted in ciliopathy phenotypes (ventrally curved body axis, hydrocephalus, 
smaller eyes and otolith defects at 3-4 dpf; upper and middle panels, otoliths indicated by 
arrowheads; scale bars = 500 or 50 ȝm, respectively). Lower panels: cartilage visualisation 
using Alcian Blue staining 4.5 dpf revealed impaired craniofacial cartilage development in 
nek1 morphants compared to control MO-injected embryos. These defects resembled, but 
were less severe, than those for zebrafish smo mutant embryos. Scale bar = 200 ȝm. (e) Co-
injection of 1.5ng nek1 MO1 with 150pg human wild-type (WT) C21orf2 RNA (three 
independent experiments, total n=76 embryos) caused significant but incomplete phenotypic 
rescue, whereas RNA expressing the C21orf2 missense mutation p.Arg73Pro (C21orf2-
p.Arg73Pro; three experiments, total n=72 embryos) rescued less effectively compared to 
negative control (#). Co-injection of 150pg C21orf2-p.Leu224Pro (three experiments, total 
n=91 embryos) had a marginal effect on rescue. Significance of pair-wise comparisons with 
the negative nek1 MO1-only control (#), or other comparisons indicated by braces, are: n.s., 
not significant; * p<0.05, ** p<0.01, **** p<0.0001 (unpaired two-tailed Student’s t-test). 
 
TABLE LEGENDS 
Table 1. Validated hits from secondary and tertiary screens of ciliogenesis. Secondary 
screen hits are listed (n=68, validated from a total of 194 functional candidates) that had a 
significant effect on ciliogenesis in mouse mIMCD3 cells (given by robust z scores if zcilia< 
zcilia cutoff = -1.34, calculated as the median z of positive controls) for n>=1/4 individual siRNAs 
duplexes in duplicate. Tertiary screen hits in human hTERT-RPE1 cells for defects in cilia 
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number and/or length (n=37/68, using cut-offs of z<-2 or z>+2) for siRNA pools in duplicate. 
Human and mouse gene symbols, mouse gene IDs, known or inferred protein function and 
selected OMIM annotations are also listed. 







Mouse 
Gene ID 
Mouse Gene 
Symbol 
Human 
Gene 
Symbol 
mIMCD3 siRNA hTERT-RPE1 siRNAs
Protein function OMIM examples (number) #1 #2 #3 cilia 
number 
cilia 
length 
76719 1700081L11Rik KANSL1 -2.13   -5.20 -5.05 histone acetyltransferase Koolen-De Vries syndrome (610443)
67884 1810043G02Rik C21orf2 -1.72 -1.67  +4.94 centriolar protein
69612 2310037I24Rik KANSL2 -2.97 -2.52 -2.28 histone acetyltransferase
67217 2810055F11Rik C14orf149 -1.69   isomerase activity
71617 9130011E15Rik C10orf76 -4.20   membrane protein
30806 Adamts8 ADAMTS8 -1.78   metalloendopeptidase
268822 Adck5 ADCK5 -2.28   protein serine/threonine kinase
11768 Ap1m2 AP1M2 -2.15 -1.62  +2.05 post-Golgi vesicle-mediated transport
11910 Atf3 ATF3 -2.94 -2.03 -1.90 transcription factor
242341 Atp6v0d2 ATP6V0D2 -1.34   +14.57 -7.03 ATP hydrolysis/proton transport
14595 B4galt1 B4GALT1 -2.94   -3.06 +4.24 post-translational protein modification Congenital disorder of glycosylation IId (607091)
12419 Cbx5 CBX5 -2.55 -2.53  transcription factor
77048 Ccdc41 CCDC41 -4.41 -2.45  -11.25 -3.37 centriolar protein
217232 Cdc27 CDC27 -7.38   mitotic cell cycle
214498 Cdc73 CDC73 -2.35   mitotic cell cycle Hyperparathyroidism, familial primary (145000)
225523 Cep120 CEP120 -1.95 -1.47  centrosomal protein Jeune asphyxiating thoracic dystrophy
12922 Crhr2 CRHR2 -4.32   corticotrophin-releasing factor 
227292 Ctdsp1 CTDSP1 -2.46   CTD phosphatase activity
83603 Elovl4 ELOVL4 -2.16   +2.14 detection of visible light Macular dystrophy, autosomal dominant (600110)
14428 Galr2 GALR2 -2.57   -2.78 galanin receptor
14563 Gdf5 GDF5 -3.67   growth factor activity Brachydactyly, type C (113100)
384009 Glipr2 GLIPR2 -1.37   Golgi membrane
70771 Gpr173 GPR173 -2.27   orphan G-protein coupled receptor
239530 Gpr20 GPR20 -2.36   +6.45 orphan G-protein coupled receptor
15107 Hadh HADH -2.74 -2.20  fatty acid beta-oxidation 3-hydroxyacyl-CoA dehydrogenase deficiency (231530)
15551 Htr1b HTR1B -2.92 -2.70  -2.93 serotonin receptor
59026 Huwe1 HUWE1 -6.62   -2.23 base-excision repair Mental retardation, X-linked, Turner type (300706)
15959 Ifit3 IFIT3 -2.78 -1.86  +2.98 type I interferon-mediated signaling
16535 Kcnq1 KCNQ1 -2.39   potassium ion export Long QT syndrome-1 (192500)
16663 Krt13 KRT13 -3.22   keratin filament White sponge nevus (193900)
109594 Lmo1 LMO1 -2.70 -1.99  -2.58 metal ion binding Leukemia, T-cell acute lymphoblastic (613065)
27756 Lsm2 LSM2 -3.14 -2.62 -2.12 -7.95 -2.35 RNA splicing
66373 Lsm5 LSM5 -2.32 -2.05  -3.36 RNA splicing
17171 Mas1 MAS1 -2.26 -1.93  angiotensin type II receptor
51812 Mcrs1 MCRS1 -3.96 -2.38  -8.30 -3.26 histone acetyltransferase
17349 Mlf1 MLF1 -2.23   +3.33 transcription, DNA-dependent Leukemia, acute myeloid (601626)
17751 Mt3 MT3 -2.13   +3.69 protein import into nucleus
17754 Mtap1a MAP1A -1.88   -5.55 microtubule-associated complex
217166 Nr1d1 NR1D1 -2.19   +2.15 steroid hormone receptor
192292 Nrbp1 NRBP1 -2.76   1.65 protein kinase
77976 Nuak1 NUAK1 -3.45   +4.60 -2.94 response to DNA damage stimulus
237222 Ofd1 OFD1 -3.97 -2.75 -2.63 +2.96 primary cilium protein Oral-facial-digital syndrome 1 (311200)
404315 Olfr372 OR2Z1 -1.57   +3.97 olfactory receptor
258961 Olfr631 OR51M1 -3.33 -1.44  olfactory receptor
14539 Opn1mw OPN1MW -1.36   -3.79 -3.00 vision perception Colorblindness, deutan (303800)
12057 Opn1sw OPN1SW -2.35   photoreceptor outer segment Colorblindness, tritan (190900)
18389 Oprl1 OPRL1 -1.54   nociceptin receptor
140795 P2ry14 P2RY14 -2.14 -1.98  purinergic nucleotide receptor
93714 Pcdhga6 PCDHGA6 -2.98   calcium ion binding
52023 Pibf1 PIBF1 -3.45 -1.76  -6.81 centrosomal protein
20873 Plk4 PLK4 -2.10 -1.63  -4.03 +2.77 mitotic cell cycle Microcephaly and chorioretinopathy (616171)
68988 Prpf31 PRPF31 -10.50 -6.64  +2.35 spliceosome RNA splicing Retinitis pigmentosa 11 (600138)
230596 Prpf38a PRPF38A -8.07   -8.26 spliceosome RNA splicing
68879 Prpf6 PRPF6 -9.51 -6.54 -5.89 -3.11 spliceosome RNA splicing Retinitis pigmentosa 60 (613983)
192159 Prpf8 PRPF8 -14.42 -9.26  -8.65 spliceosome RNA splicing Retinitis pigmentosa 13 (600059)
74760 Rab3il1 RAB3IL1 -2.00   +4.81 Rab guanyl-nucleotide exchange 
19387 Rangap1 RANGAP1 -2.71 -1.53  Ran GTPase activator 
19400 Rapsn RAPSN -2.36   +4.84 acetylcholine receptor binding Myasthenic syndrome, congenital (608931)
56438 Rbx1 RBX1 -6.22   DNA repair
216227 Slc17a8 SLC17A8 -3.28 -1.41  +2.35 L-glutamate transmembrane Deafness, autosomal dominant 25 (605583)
20526 Slc2a2 SLC2A2 -1.60   D-glucose transmembrane transporter Fanconi-Bickel syndrome (227810)
83701 Srrt SRRT -3.08 -2.42 -1.77 primary miRNA processing
66592 Stoml2 STOML2 -3.62   mitochondrial inner membrane protein
67902 Sumf2 SUMF2 -2.33 -1.93  +3.70 endoplasmic reticulum lumen protein
78829 Tsc22d4 TSC22D4 -2.05 -1.53  transcription factor
56085 Ubqln1 UBQLN1 -2.01   regulator of protein ubiquitination
28035 Usp39 USP39 -6.08 -4.89  -3.64 +8.37 RNA splicing
74716 Wbp2nl WBP2NL -2.12   -3.16 meiotic protein
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SUPPLEMENTARY DATA 
Supplementary Figure 1. Characterization of the antibody specificities and sub-cellular 
localizations of hit G protein-coupled receptors. (a) Localization of the indicated GPCRs 
(green; with grey-scale image for the green channel on the right) for mIMCD3 cells to the 
ciliary base (white arrowheads). GPCRs include GPR20 (orphan G-protein coupled receptor 
20), GPR173 (orphan G-protein coupled receptor 173), CRHR2 (corticotropin releasing 
hormone receptor 2), HTR1B (5-hydroxytryptamine/serotonin receptor), MAS1 (MAS1 proto-
oncogene receptor), OPRL1 (opioid receptor-like 1), P2RY14 (purinergic receptor P2Y, G-
protein coupled, 14) and RAPSYN (receptor-associated protein of the synapse). Knock-down 
with the cognate siRNA pools for all GPCRs caused loss of primary cilia (visualized by 
acetylated α-tubulin; red), compared to scrambled (scr.) negative control. Scale bar = 5 µm. 
(b) Localization of GPCRs (green) to the base of primary cilia (stained for polyglutamylated 
α-tubulin or γ-tubulin as indicated; red) in the different cortical layers of Tmem67+/+ wild-type 
embryonic (E18.5) mouse neocortex (left panels). In Tmem67-/- knock-out embryos mutated 
for the transition zone receptor TMEM67, the ciliary localization of GPCRs was lost (right 
panels). Images are representative of two independent experiments. Scale bar = 20µm. 
Magnified regions are shown in the smaller panels. 
 
Supplementary Figure 2. Mutations in PIBF1 cause Joubert syndrome. Homozygosity 
mapping and pedigrees for Hutterite families with Joubert syndrome. (a) Plot of SNP 
genotypes in family H1, showing two large intervals of absence of heterozygosity (red lines) 
on chromosomes 10 and 13. (b) Pedigrees showing segregation of c.1910A>C in PIBF1 
(NM_006346.2) in Hutterite families H1 to H4 with Joubert syndrome. * indicates individuals 
with microphthalmia and anterior segment dysgenesis that does not segregate with the 
homozygous variant. NA, not available. (c) Electropherogram of the homozygous PIBF1 
mutation c.1910A>C p.Asp637Ala in affected individual H1-4 compared to a control 
individual, indicated by red arrowhead. (d) Pedigree and electropherograms for the 
compound heterozygous PIBF1 variants c.1669delC p.Leu637Phefs*18 and c.1214G>A 
2 
p.Arg405Gln in affected individual UW155-3 with Joubert syndrome, indicated by red 
arrowheads. (e) Pedigree of family MTI-121 with compound heterozygous PIBF1 variants 
c.1214G>A p.Arg405Gln and a genomic deletion encompassing exons 6 to 9 (c.673-
?_1322+?del) of PIBF1 in affected individuals II.5 and II.7. Electropherogram of the 
hemizygous c.1910A>C mutation in PIBF1 in affected individual II:2 (lower 
electropherogram), indicated by the red arrowhead, as compared to a control individual 
(upper electropherogram). 
 
Supplementary Figure 3. Range of brain MRI findings in individuals with PIBF1-related 
Joubert syndrome. (a-c) Mild vermis hypoplasia, mildly elevated and thickened superior 
cerebellar peduncles (arrowhead), and superior cerebellar dysplasia (arrow) in H1-3. (d-i) 
Classic molar tooth sign in H2-4 and H3-3. (j-l) Classic molar tooth sign with more severe 
vermis hypoplasia, cervicomedullary heterotopia (white arrow), and foramen magnum 
cephalocele (white arrowhead) in H4-3. (a, d, g, j) are T1-weighted images. (b, c, e, f, h, i, k, 
l) are T2-weighted images. 
 
Supplementary Figure 4. Ciliogenesis rescue experiments with PIBF1 and C21orf2 
missense mutations. Bar graphs show % ciliated mIMCD3 cells following reverse 
transfection with either scrambled (scr.) negative control or gene-specific pooled siRNAs, 
and the indicated FLAG-tagged expression constructs. Ciliogenesis was assayed by 
automated high content imaging in 96-well plates (see On-line Methods and 
Supplementary Note for details), with additional immunostaining with anti-FLAG for 
normalization of protein expression levels. Values are derived from six fields of view for n=3 
independent experiments, expressed as percentages of the % ciliated cells value following 
scrambled siRNA and empty vector transfection (indicated by #), with the statistical 
significance of pair-wise comparisons as follows: * p<0.05, ** p<0.01 and *** p<0.001; n.s., 
not significant (unpaired two-tailed Student’s t-test). Other pair-wise comparisons are 
indicated by braces. Error bars indicate standard error of the mean. 
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Supplementary Figure 5. Mutations in C21orf2 cause Jeune syndrome. (a-f) Overview of 
Jeune family pedigrees that carry C21orf2 (NM_004928.2) mutations and show segregation 
consistent with an autosomal recessive inheritance pattern. All affected individuals have 
cone-rod dystrophy (CRD) with the exception of GC4693.1 shown in (b) who has mild retinal 
degeneration (RD) marked by an asterisk. The key indicates phenotypic variability of the 
skeletal features ranging from severe (black symbol), mild (mixed symbol) to absent (grey 
symbol). Consanguineous unions are indicated by double lines. (e) Electropherogram 
showing the effect of the c.545+1C>T mutation by RT-PCR performed on cDNA derived from 
RNA isolated from peripheral blood cells from individual F2.1 (lower electropherogram) 
compared to control individual (upper electropherogram). c.545+1C>T results in deletion of 
five nucleotides at the 3’ end of C21orf2 exon 5, causing a predicted frame-shift of the 
protein product. (f) Predicted effects of the C21orf2 c.96+6 T>A variant on splicing in patient 
UCL-78.1. Left panel: visualisation of splicing probabilities for wild-type and mutant C21orf2 
c.96+6 T>A sequence (red text) using Alamut software. Gene Splicer predicts a lack of 
splicing for the mutant compared to wild-type (wildtype score 1.73, mutant 0; range 0-15); 
MaxEnt predicts a reduction of splicing probability of 40.1 % (reduction from 9.11 to 5.46; 
range 0-12); NNS splice predicts a reduction of splicing probability for the mutant of 11.6 % 
(wild-type score 0.99, mutant 0.87, range 0-1); SSF predicts a splicing probability reduction 
for the mutant of 6.3% (wild-type score 88.33, mutant 79; range 0-100) and HSF predicts a 
splicing probability reduction of 2.7% (wild-type score 87.37, mutant 85.04, range 0-100). 
Right panel: visualisation of predicted splicing enhancer binding sites using Alamut software 
shows loss of an SRp55 enhancer (highlighted in yellow) in the mutant C21orf2 c.96+6 T>A 
sequence (red text) compared to wild-type. 
 
Supplementary Figure 6. Subcellular localisation of C21orf2. (a) Indirect 
immunofluorescence showing co-localization of C21orf2 (green) with γ-tubulin (red) in ciliary 
regions in longitudinal sections of adult mouse retinas. Magnified inset indicated by white 
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frame. Abbreviations: CR, ciliary regions of photoreceptor cells; ONL, outer nuclear layer; 
RPE, retinal pigment epithelium. Scale bar = 50µm. (b) Immunohistochemical detection of 
C21orf2 in bone primordia of mouse embryonic ribs and hip joints at E14.5 and E18.5, 
respectively (arrowheads). Scale bars = 0.1mm. (c) Upper panel: over-expressed eCFP-
C21orf2 (cyan) localizes to the cytoplasm with enrichment at the base of the cilium in 
hTERT-RPE1 cells (arrowhead). Second panel: eCFP-C21orf2 co-localizes with mRFP-
NEK1 (red) in the cytoplasm and at the base of the cilium (arrowhead). Third panel: eCFP-
C21orf2 is recruited to the microtubule network via its interaction with mRFP-SPATA7 (red). 
Lower panel: in the presence of mRFP-SPATA7 (red), both eCFP-C21orf2 (cyan) and 
3xFLAG-NEK1 (magenta) are localized to the microtubule network (yellow). Acetylated (Ac) 
α-tubulin antibody is used as a marker for cilia and the microtubule network 
(red/magenta/yellow), γ-tubulin antibody is used to stain basal bodies and DAPI (blue) is 
used to stain nuclei. Primary cilia indicated by arrowheads are shown in magnified insets. 
Scale bars = 10 µm. 
 
Supplementary Figure 7. Validation of the NEK1 antibody, GST pull-downs of 
endogenous NEK1 by GST-C21orf2 and GST-SPATA7 fusion proteins from bovine 
retinal extract, and phenotypes of nek1 morphant zebrafish embryos. (a) Upper panel: 
western immunoblot with affinity-purified rabbit polyclonal raised against hNEK1H3T1 
(1:2000; red frame) for WCEs from control fibroblasts (C), patient fibroblasts (N) with a 
homozygous NEK1 nonsense mutation1 in exon 5 treated with either normal media (5) or 
serum-starved (0), and HEK293 cells (H). Control fibroblasts and HEK293 cells express full-
length NEK1 (predicted size 140kDa) that is absent in patient fibroblasts. Loading control is 
β-actin (1:3000; green frame). Lower panel: IF labelling of basal ciliary regions in serum-
starved control fibroblasts by affinity-purified anti-NEK1 (green; region in magnified inset 
indicated by arrowhead) with primary cilia labelled with acetylated (Ac) α-tubulin (red). Scale 
bar = 10µm. (b) Upper panel: Simply Blue stain of gel showing 10% input GST negative 
control (lane 2) and GST-fusion proteins GST-C21orf2 and GST-SPATA7 (lanes 3-4). Lower 
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panel: immunoblot (IB) for endogenous NEK1 on input bovine retinal extract (lane 1) and 
material pulled down from bovine retinal extract by GST-C21orf2 and GST-SPATA7 (lanes 2-
4). (c) Verification of morpholino oligonucleotide (MO) effects using RT-PCR. For the nek1 
morpholino oligonucleotide (MO1) targeting the exon6 splice donor site, the wild-type product 
size is approx. 750 bp whereas MO-injected embryos result in a product of approximately 
1250 bp suggesting inclusion of intron 6/7 (intron length 575 bp; see On-line Methods for 
further details). Amplification of gapdh shows approximately equal cDNA input. (d,e-) H&E 
staining of eyes of embryos injected with 2ng nek1 MO1 revealed both a reduced outer 
nuclear layer and generally smaller eyes compared to controls. Abbreviations: INL= inner 
nuclear layer, ONL= outer nuclear layer. Scale bar = 50 µm. (f,g) 2ng nek1 MO1 injections in 
rhodopsin:GFP transgenic embryos caused loss of photoreceptor cells (arrows) at 4 dpf 
compared to controls. Scale bar = 25 µm. (h,i) Acetylated (Ac) α-tubulin staining of nek1 
MO1-injected embryos revealed a severe reduction of cilia length in the pronephros 
compared to control embryos (cilia indicated by arrows). Cilia length appeared normal in the 
neural tube (data not shown). Scale bar = 10 µm. 
 
Supplementary Figure 8. Full images of SDS-PAGE gels/western blots. Full 
unprocessed SDS-PAGE gel images and signals detected upon western blotting, with the 
regions used in the corresponding main display items indicated by red frames. 
 
Supplementary Table 1. Complete dataset for the genome-wide siRNA primary screen 
for ciliogenesis. The first spreadsheet ("All results, robust z scores") summarises the results 
of the whole genome mouse siRNA screen performed in mIMCD3 cells and lists robust z 
scores for % cells with a single cilium (zcilia) and whole cell number (zcell). This spreadsheet 
details: the mouse gene symbol and Entrez GeneID, the gene symbol of the human 
orthologue (if any) and Entrez GeneID, sublibrary and plate position of the siRNA pool, and 
the results for % cells with a single cilium and whole cell number after 72 hours siRNA 
knockdown. The screen results are expressed as robust z scores, and these are calculated 
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per 10-plate batch. Each siRNA pool has two results (run 1 and run 2), which represent two 
independent biological replicates. As an arbitrary measure, z=-2 is usually considered an 
acceptable z score cutoff for significant hits. It is more meaningful, however, to set the cutoff 
according to the median robust z score of the positive controls. For this reason, the median 
and median absolute deviation (MAD) robust z scores of the positive controls are given for 
each batch in columns next to the test results. If a test result is greater in value than the 
median robust z score for the positive controls (zcilia< zcilia cutoff) for both replicates, then this 
siRNA has a greater effect on ciliogenesis than the median of the positive controls and the 
result is taken as a significant hit. Results are presented in batches in order of their 
processing in chronological time. Within each batch, the results are ordered by average 
robust z score for % cells with a single cilium. Cells indicated in the "Fail" column should be 
interpreted with caution: the results in columns A and H in run 2 of batch mDT51-60 are not 
reliable because of technical issues with primary antibody application. Plate mG37 in run 1 
had to be repeated because of technical issues, and is therefore analysed independently 
from the rest of batch mG31-40 with different median and MAD values for the controls. The 
first spreadsheet ("All results, robust z scores") also lists additional information about the 
mouse gene including Genetic Ontology codes, phenotypes of any mouse models (from 
MGI) and GeneRIFs (from NCBI). Human orthologues are also listed, with additional 
summaries of known or inferred function of the encoded protein and any OMIM annotations. 
The next two tabs list genes that are only partially targeted by siRNA (i.e. not all transcripts 
were targeted by the siRNA reagent) or have off-target effects (i.e. the siRNA reagent targets 
transcripts from genes other than the one it was designed for). Both of these lists are derived 
from BLASTN analyses of all siRNA duplex sequences in the ThermoFisher siGENOME 
library. Genes are listed by Entrez GeneID. The fourth tab lists genes by NCBI GeneID with 
abnormal copy number generated by the analysis of array CGH data. '-2' indicates a biallelic 
deletion, '-1' monoallelic deletion, '1' monoallelic duplication, '2' biallelic duplication. Genes 
with two or more values indicate that the siRNA duplexes had potential off-target effects. The 
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fifth tab lists genes by NCBI GeneID with siRNAs that have potential miRNA-like effects, as 
determined by analysis for seed sequences by GESS. 
 
Supplementary Table 2. Complete dataset for primary screen hits. The spreadsheet lists 
robust z scores for % cells with a single cilium (zcilia) and whole cell number (zcell) for primary 
screen hits following screening in mIMCD3 cells. Details are as for Supplementary Table 1. 
In total, 2174 siRNA pools significantly decreased the percentage of cells with a single 
primary cilium (zcilia< zcilia cutoff in a processed batch for both replicates, where zcilia cutoff = 
median z of all positive controls), with 1956 hits targeting a gene with a human orthologue. 
Potential non-specific siRNAs comprising those with predicted off-target effects (n=115) or to 
have microRNA-like effects (n=12) left a total of 1829 mouse genes with a human 
orthologue. 
 
Supplementary Table 3. Complete datasets for secondary and tertiary screen hits. The 
spreadsheets list robust z scores for % cells with a single cilium (zcilia) and whole cell number 
(zcell) for secondary and tertiary screen hits following screening in mIMCD3 and hTERT-
RPE1 cells. The first spreadsheet (IMCD3 secondary screen 1) lists n=40 out of the 1829 
primary screen hits that had human orthologues and were functional candidates and 
representative components of a significantly enriched pathway that was predicted by DAVID 
analysis. Results are given for four individual siRNA duplexes for each gene, listing gene ID 
and mouse gene symbol. The second spreadsheet (IMCD3 secondary screen 2) lists n=154 
hits with human orthologues following filtering of the 1829 primary screen hits for those that 
significantly affect the percentage of cells with a single cilium (zcilia) but did not have a 
significant effect on cell number (zcell>zcell cutoff in a processing batch for both replicates, where 
zcell cutoff=median z-2MAD for all negative controls). Results are given for four individual siRNA 
duplexes for each gene, listing gene ID and mouse gene symbol. The third spreadsheet lists 
robust z scores for cilia length (zcilia length) and % cells with a single cilium (zcilia) for n=68 
secondary screen hits following re-screening with pooled siRNAs in hTERT-RPE1 cells. 
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Results are given for pooled siRNA duplexes for each gene, listing gene ID and mouse gene 
symbol and gene symbol of the human orthologue. 
 
Supplementary Table 4. Complete dataset for secondary screen of ubiquitin-
proteasome system (UPS) hits. Primary screen hits are listed (n=57), with a total of 
n=34/57 genes with a significant effect on ciliogenesis (robust z scores ≤-2 or ≥+2; 
highlighted by red or green text, respectively) and n=29/57 with a significant effect on cilium 
length (robust z scores ≤-2 or ≥+2) versus in-plate non-targeting (NT) control duplexes, for 
n≥2 out of 3 individual siRNA duplexes using hTERT-RPE1 cells. A total of n=44/57 genes 
had a significant effect on cilia number and/or cilia length ciliogenesis. Human Entrez gene 
symbol, gene ID, siRNA ID and siRNA sequences are listed. Transfection and image 
analysis methods were the same as for the tertiary screen, listing robust z scores for cilia 
length (zcilia length) and for % cells with a single cilium (zcilia). 
 
Supplementary Table 5. Variants identified by whole-exome sequencing in patients 
with Joubert and Jeune syndromes. Genes with causative mutations are underlined. 
Abbreviations: dam, damaging; del, deleterious; EVS, Exome Variant Server; GS, Grantham 
Score; MAF, Minor Allele Frequency; neut, neutral; P2, Polyphen2; prob, probably; tol, 
tolerated. *COL18A1: mutations cause Knobloch syndrome, (KNO1; OMIM #267750) an 
autosomal recessive disorder defined by high myopia, vitreoretinal degeneration with retinal 
detachment, macular abnormalities, and occipital encephalocele. 
 
Supplementary Table 6. MRI features of Joubert patients with PIBF1 mutations. 
Abbreviations: d, days; DD, developmental delay; F, female; M, male; mo, months; L, left; 
MTS, molar tooth sign; na, not applicable; nd, not determined; PMG, polymicrogyria; R, right; 
SC, superior cerebellum; SCP, superior cerebellar peduncle; yr, years; ?, unknown. 
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Supplementary Table 7. Clinical features of ciliopathy patients. a individuals CR and F2 
have been described previously23; b C21orf2 c.218C>G annotated as variant rs140451304 
(ExAC allele calls C=111976/G=37); c individual investigated by CT imaging only; d tonic 
seizures in infancy; e complex eye defects (microphthalmia, opaque corneas, severe 
mesodermal dysgenesis); f high hyperopic refractive error; g mild retinal degeneration; 
Abbreviations: d, days; DD, developmental delay; F, female; M, male; mo, months; MTS, 
molar tooth sign; na, not applicable; nd, not determined; OMA, oculomotor apraxia; SD, 
splice donor; VHD, vermis hypoplasia and cerebellar dysplasia; yr, years; ?, unknown. 
 
Supplementary Table 8. Strep-tag II/FLAG tandem-affinity purification (SF-TAP) and 
mass spectrometry analysis of SF-TAP-tagged C21orf2, NEK1 and SPATA7 in HEK293 
cells. Three individual SF-TAP experiments N-terminal (n=2) and C-terminal (n=1) SF-TAP-
tagged C21orf2 (pale yellow columns), NEK1 (green columns) and SPATA7 (purple 
columns) were performed. Listed are the SWISS Prot Accession numbers, Entrez gene 
symbol and name, unique peptides and sequence coverage for the preys identified per TAP 
experiment and for the majority of TAP experiments per bait protein. Rows for C21orf2, 
NEK1 and SPATA7 are highlighted in yellow. 
 
Supplementary Table 9. Mass spectrometry analysis of NEK1 endogenous co-
immunoprecipitation and GST pull-down of SPATA7 from bovine retinal lysates. 
Unique peptide counts for C21orf2, NEK1 and SPATA7 from mass spectroscopy analysis are 
listed for immunoprecipitation (IP) experiments (n=3 biological replicates) with anti-NEK1 
antibody compared to anti-FLAG negative control, and GST pull-down assays with GST-
SPATA7 fusion protein compared to GST negative control. Protein symbols, Uniprot 
accessions (Acc.) and names are listed. 
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Supplementary Table 10. Sequences of siRNA duplexes used to target positive and 
negative control genes for ciliogenesis in mIMCD3 cells. 
 
Supplementary Table 11. Complete dataset for additional ciliopathy and ciliary-related 
hits. Dataset for n=780/1829 of the total hits from the primary screen with an effect on cilia 
number that is significantly greater (z>+2) than any effect on cell number. Details are as for 
Supplementary Table 1. 
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ON-LINE METHODS AND MATERIALS 
Cell culture 
Mouse inner medullary collecting duct (mIMCD3), human telomerase reverse transcriptase-
transformed retinal pigment epithelium (hTERT-RPE1) and human neuroblastoma (SH-SY5Y) 
cells were derived from American Type Culture Collection (ATCC) and maintained in 
DMEM/Ham’s F12 medium supplemented with 10% foetal calf serum (FCS), under standard 
conditions (37oC, 5% CO2). Cells were passaged at a split ratio of 1:10 twice a week. mIMCD3 
cells were obtained from ATCC at passage 13 and were used for screening purposes between 
passage 17 and 25. SH-SY5Y cells were differentiated over 6 days by retinoic acid (RA) 
treatment followed by brain derived neurotrophic factor (BDNF) treatment. Cells were plated in 
standard culture medium for 24 hours, in standard medium containing 10ȝM RA for 3 days and 
in serum-free medium containing 50ng/ml BDNF cells for 3 days. Human dermal fibroblasts 
were derived from skin biopsies and cultured in fibroblast growth medium (Genlantis). hTERT-
RPE1 cells were serum starved in normal media with 0.2% FCS for 48 hours to induce 
ciliogenesis. 
 
Mice 
C57Bl/6J wild-type mice and the B6;129P2-Tmem67tm1Dgen/H line were kept on a 12 h light-dark 
schedule with unlimited access to food and water. All procedures were in accordance with local 
laws on animal protection, the ARVO Statement for the Use of Animals in Ophthalmic and 
Vision Research, and under the guidance issued by the Medical Research Council in 
Responsibility in the Use of Animals for Medical Research (July 1993) in accordance with UK 
Home Office regulations under the Project Licence no. PPL40/3349.  
 
Plasmids 
Full-length Gateway Entry clones for human C21orf2 (IOH23207), SPATA7 (IOH62585), PRPF6 
(IOH3880), PRPF31 (IOH41469) and PRPF38A (IOH46080) were kindly provided by Nico 
Katsanis (Duke University, Durham, USA). Human PIBF1 (kindly provided by Kym Boycott) and 
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NEK1 (NM_012224.2, kindly provided by Andreas Gießl) were cloned into the Gateway system 
(LifeTechnologies). Full-length NPHP4, amino acids 611-1286 of RPGRIP1 and the LRR 
domain of LRRK2 constructs were generated as previously described31 and cloned into the 
Gateway system. Entry clones were sequence-verified and further cloned into HA-, GST-, 
FLAG-, mRFP, eCFP and strep-II tag/FLAG-tandem affinity purification (SF-TAP)-tagged 
destination vectors using the Gateway system. Missense mutations for PIBF1 and C21orf2 were 
introduced with the Q5 Site-Directed Mutagenesis Kit (New England Biolabs), using conditions 
recommended by the manufacturer. 
 
Generation of hNEK1 specific antibody 
A 444 bp hNEK1 (NM_012224) cDNA (hNEK1 H3T1; 1759-2202 bp, encoding amino acids 587-
734)35 was cloned into the pGEX-4T3 expression vector (GE Healthcare Life Sciences) using 
BamHI and XhoI restriction sites. Expression and purification of the GST fusion protein was 
performed according to the manufacturer’s instructions (GE Healthcare Life Sciences). After 
cleavage of the fusion protein with thrombin on the column, hNEK1H3 was eluted with 1 x PBS 
followed by peptide immunization of rabbits by a commercial supplier (Pineda Antikörper-
Service, Berlin, Germany). Polyclonal antisera against recombinantly-expressed hNEK1H3T1 
were affinity-purified on high trap N-hydroxysuccinimide columns (HiTrap NHS-Activated HP; 
product code:17-0716-01; GE Healthcare Life Sciences). Validation experiments for antisera are 
shown in Suppl. Figure 7a. 
 
Antibodies and staining reagents for immunofluorescence 
The following antibodies were used with the indicated titres for immunofluorescent staining: 
rabbit anti-PRP6 (Santa Cruz sc-48786) 1:100, mouse anti-PRPF8 (Santa Cruz sc-55534) 
1:100, rabbit anti-PRPF8 (Santa Cruz sc-030207) 1:100, goat anti-PRPF31 (Abnova PAB7154) 
1:100, PIBF1/CEP90 (Novus NBP2-19823) 1:100, rabbit anti-PLK4 (Cell Signalling 
Technologies 3258) 1:100, rabbit anti-GPR20 polyclonal (Thermo Scientific, PA3-068) 1:100, 
rabbit anti-SREB3 (Novus Biologicals NBP1-71064) 1:100, rabbit anti-MAS1 (Novus Biologicals 
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NBP1-78444) 1:100, rabbit anti-HTR1B (Novus Biologicals NBP1-01013) 1:100, rabbit anti-
P2RY14 (Novus NBP1-70970) 1:100, rabbit anti-CRHR2 (Novus NBP1-00767) 1:100, rabbit 
anti-OPRL1 (Abcam ab66219) 1:50, rabbit anti-C21orf2 (GeneTex [N1C2], GTX119046) 1:100, 
mouse anti-acetylated alpha tubulin (Sigma Aldrich clone 6-11 B1 T6793) 1:1000, rat anti-ZO1 
(1:400, Santa Cruz), rabbit anti-ȕ-catenin (1:400, BD Bioscience), rabbit anti-gamma tubulin 
(AbCam ab11317) 1:1000, rabbit anti-ARL13B (Proteintech 17711-1-AP) 1:1000, mouse anti-
GT335 monoclonal (Enzo Life Sciences ALX-804-885-C100) 1:1000 and mouse anti-FLAG 
(Sigma F3165) 1:1000. The mouse monoclonal antibody against centrin-3 has been described 
previously36. Secondary antibodies were Alexa-Fluor-conjugated goat anti-mouse IgG and goat 
anti-rabbit IgG (Life Technologies Ltd.) 
 
siRNA rescue experiments in mIMCD3 
Rescue experiments followed our standard siRNA transfection and image analysis protocols for 
pooled siRNA mouse siGENOME siRNAs (Thermo Scientific) in mIMCD3 cells for either Pibf1 
or C21orf2. Reverse transfections in 96-well assay plates (PerkinElmer View Plates) included 
100ng of wild-type or missense mutated FLAG-tagged human PIBF1 or C21orf2 constructs. Our 
standard high-content image analysis protocol was adapted to include immunofluorescent 
staining with anti-FLAG to enable quantitation of transfection efficiency. 
 
Immunofluorescence and confocal microscopy of hTERT-RPE1 and mIMCD3 cells 
hTERT-RPE1 cells were cultured as described above. To induce ciliogenesis, cells were 
seeded on coverslips and serum starved (culture medium with 0.2% FCS) for 24 hrs prior to 
transfection. Subsequently, Lipofectamine2000 (LifeTechnologies) was used to transfect cells 
with the appropriate vector according to the manufacturer’s protocol. 24 hrs post-transfection, 
ciliated cells were fixed in 2% PFA for 20 minutes, treated with 1% Triton X-100 in PBS for 5 
minutes, and blocked in 2% bovine serum albumin (BSA) in PBS for 30 minutes. Fixed cells 
were stained for 1 hour with the corresponding primary antibodies: rabbit anti-FLAG (Sigma-
Aldrich) 1:1000 and mouse anti-acetylated alpha tubulin (Sigma-Aldrich) 1:1000. Coverslips 
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were then washed in PBS and stained for 45 minutes with AlexaFluor-405 or AlexaFluor-647-
conjugated secondary antibodies (1:500, LifeTechnologies). Coverslips were washed again with 
PBS and briefly with milliQ water before mounting in Vectashield with or without DAPI (Vector 
Laboratories). mIMCD3 cells were seeded at 2.5x105 cells/well on sterile glass coverslips in six-
well plates and fixed in ice-cold methanol. Cells were blocked in 1% non-fat milk for 5 min each. 
Immunofluorescence staining was performed as described previously37. 
Confocal images were obtained using a Zeiss Axio Imager ZI fluorescence microscope 
(Zeiss), equipped with a 63x objective oil lens, or a Nikon A1R confocal microscope with x100 
oil objective lens controlled by NIS-Elements AR 4.20.01 (Nikon) software. Optical sections 
were generated through structured processed using Axiovision 4.3 (Zeiss) or NIS-Elements AR 
4.20.01 (Nikon) software. Images were analysed using Adobe Photoshop CS and FIJI software. 
Images were assembled with Adobe Illustrator CS. 
 
mIMCD3 spheroid assay 
1x104 mIMCD3 cells per well were seeded in a 48 well-plate and transfected using 
Lipofectamine RNAiMax (LifeTechnologies) according to the manufacturer’s protocol. Cells 
were trypsinized 24 h post-transfection and resuspended cells were then mixed 1:1 with growth 
factor-depleted Matrigel (BD Bioscience) in Labtech chamber slides. After polymerization for 20 
min at 37°C, warm medium was dripped over the matrix until just covered. The mIMCD3 cells 
formed spheroids with cleared lumens 3 days later. Medium was removed by pipetting and the 
gels were washed three times for 10 min with warm PBS supplemented with Ca2+ and Mg2+. The 
gels were then fixed in fresh 4% PFA for 30 min at room temperature. After washing three times 
in PBS, the cells were permeabilized for 15 min in gelatin dissolved in warm PBS (350 mg/50 
ml) with 0.5% Triton X-100. Primary antibody (mouse anti-acetylated tubulin, Sigma, 1:20,000), 
rat anti-ZO1 (1:400, Santa Cruz) and rabbit anti-ȕ-catenin (1:400, BD Bioscience) was diluted in 
permeabilization buffer and incubated overnight at 4°C. After washing the spheroids three times 
for 30 min in permeabilization buffer, goat anti-mouse-Cy5, donkey anti-rabbit-TRITC, and goat 
anti-rat-FITC secondary antibodies (1:500, LifeTechnologies) were each diluted in 
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permeabilization buffer and incubated with the spheroids for 4 hr at room temperature. 
Spheroids were washed three times in permeabilization buffer for 10 min per wash and then 
incubated for 1 hr with DAPI, before being washed an additional three times in PBS, and finally 
mounted in Fluoromount-G (Cell Lab, Beckman Coulter). Images and z-stacks were taken with 
a Zeiss LSM700 confocal microscope. Cilia were counted manually from maximum projections 
of z-stacks, with axonemes >1ȝm in length scored as positive, as described previously37. 
 
Confocal immunofluorescence microscopy and high resolution immunofluorescence 
analysis of mouse photoreceptor cells 
Images were obtained using a Nikon Eclipse A1 scanning confocal microscope, controlled and 
processed using Nikon Elements software. For high magnification and high resolution 
immunofluorescence analysis eyes of C57Bl/6J mice were cryofixed, sectioned, and 
immunostained as previously described38,39 for two independent experiments. Cryosections 
were double stained for PRPF6, PRPF8 (A5463), GPR20, MAS1, SREB3, HTR1B (1:200) and 
centrin-3 (1:100) as a molecular marker for the connecting cilium, the basal body, and the 
adjacent centriole of photoreceptor cells40. Subsequently, cryosections were incubated with the 
according secondary antibodies conjugated to Alexa 488 or Alexa 555 (LifeTechnologies), 
counterstained with DAPI (Sigma-Aldrich), and mounted in Mowiol 4-88 (Hoechst). Specimens 
were analysed and deconvoluted in a Leica LEITZ DM6000B microscope (Leica). Images were 
processed with Adobe Photoshop CS using different tools including contrast and colour 
correction as well as pixel extrapolation. 
 
Immunoelectron microscopy of mouse photoreceptor cells 
For immunoelectron microscopy of mouse photoreceptor cells, the pre-embedding labelling 
protocol was used, as described previously41,42. Ultrathin sections were analysed in a 
transmission electron microscope (TEM) (Tecnai 12 BioTwin, FEI). Images were obtained with a 
charge-coupled device camera (SIS MegaView3, Olympus) and processed with Adobe 
Photoshop CS. 
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Transmission electron microscopy on C. elegans amphid channel cilia 
TEM was performed on the amphid channel cilia of strain MR247: prp-8(rr40);cdc-25.1(rr31) 
unc-13(e450); rrIs01. This strain was obtained in a forward genetic screen for suppressors of 
the cell cycle phosphatase cdc-25.1(rr31), which is a dominant maternal effect gain-of-function 
missense allele (G47D) sensitizing the intestinal lineage to an extra cell division43. The rr40 
suppressor is a homozygous donor splice site mutation (hypomorphic) in intron 8 of prp-8. 
MR247 also contains an undefined (likely missense) mutation (e450) in the neurotransmitter 
vesicle release regulator unc-13 (used to map the prp-8(rr40) mutation), and an integrated 
intestinal GFP marker (rrIs01)44. Although the prp-8 splice-site mutation is the likely cause of the 
ciliogenesis defect in this strain, we cannot formally exclude the possibility that a dominant 
missense mutation in cdc-25.1 or an undefined (likely missense) mutation in unc-13 could be 
causative for these defects. Young adult worms were processed and imaged essentially as 
described previously45, except that MR247 worms were fixed overnight at 4°C in 2.5% 
gluteraldehyde and 1% paraformaldehyde in Sørensen's buffer. 
 
Confirmation of siRNA knockdown by qRT-PCR 
QRT-PCR was conducted as previously described46. The following primers were used: 
Plk4: 5’-CGTTGTCACTCAGTAGAAATGCT, 5’-GGTGTCTGGTCTGCAAATGG; Prpf6: 5’-
AAGCTGACTCCTGTTCCTGA, 5’-TCATTCCACCTGGGTATGGAG; Prpf8: 5’-
ACTGGAAGCCATTCAGCTAGAG, 5’-AATGTGAACTGCCAGCGTTG; Prpf31: 5’-
TATCAGCAAGCAAGCCAACG, 5’-CTATCTCCACAGTCAGGTTGTTG; Prpf38a: 5’-
AAGAGCCAGAACCGAAATGG, 5’-GACTCTCTCACTGTGCAGGA; Pibf1: 5’-
CCCAGAAAAACATGATGATCGAC, 5’-CTAATCGCAAAGTTAGCAGCTG; C21orf2: 5’-
ACCTGCTGAGCTACACAGAG, 5’-TTCTTGTGACTCCTCATCGTGT; ȕ-actin: 5’- 
GCTTCTTTGCAGCTCCTTCGT, 5’-AGCGCAGCGATATCGTCAT. 
 
Western blotting 
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Whole cell extract and western blots were conducted as previously described46. Antibodies were 
used at the following concentrations: rabbit anti-PRPF6 (Santa Cruz sc-48786) 1:500, mouse 
anti-PRPF8 (Santa Cruz sc-55534) 1:200, rabbit anti-PRPF8 (Santa Cruz sc-030207) 1:200, 
goat anti-PRPF31 (Abnova PAB7154) 1:500 , rabbit anti-PLK4 (Cell Signalling Technologies 
3258) 1:500, rabbit anti-C21orf2 1:500 and rabbit anti-NEK1 (H3T1; validated in Suppl. Figure 
8a) 1:2000 incubated overnight at 4oC; and mouse anti-FLAG (Sigma Aldrich clone M2 F9291) 
1:2000, mouse anti-HA (Sigma Aldrich H9658) 1:1000 and mouse anti-β actin (Abcam ab6276) 
1:5000 incubated for 1 hour at room temperature. Membranes were incubated with HRP-
conjugated secondary antibodies (Dako Cytomation P0447 and P0448) for 1 hour at room 
temperature and immunopositive bands visualized with Supersignal West Femto 
chemiluminescent substrate (Pierce) on a BioRad ChemiDoc MP system. Full unprocessed 
western blotting scans are shown in Suppl. Figure 9, with the regions used in main display 
items indicated by red frames. 
 
Zebrafish experiments 
Zebrafish husbandry was undertaken to UK Home Office Rules under standard conditions. 
Antisense morpholino oligonucleotide (MO; Gene Tools Inc.) for nek1 (ENSDART00000035239 
zv9) were designed against the splice donor sites of exon 6 and exon 8 (exon 6 sequence MO1: 
AGCATTAAAACACATCTGACCTATT, exon 8 sequence MO2: 
GATAAGAAAGACAAGCGCACCTTCC). MO injection into embryos was performed at the one- 
to two-cell stage and embryos were incubated at 28.5°C. Effective doses were defined as the 
MO concentration that resulted in the least dead fish and the most fish with the phenotypes of 
interest. nek1 knockdown resulted in a marked embryonic lethality of about 25% even at low 
doses due to developmental defects during gastrulation. MO specificity was confirmed by RT-
PCR (Suppl. Figure 7c). RNA was extracted at 48 hpf using TRIzol (LifeTechnologies). First-
strand complementary DNA was synthesized using random nonamers (Sigma-Aldrich) and 
Omniscript transcriptase (Qiagen). Standard PCR was carried out using primers in exons 4 and 
10 for the nek1 exon 6 splice MO (expected wild-type product size approx. 750 bp, intron 6/7 
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length 575 bp), with 60 bp. RT-PCR result suggesting the inclusion of the downstream intron 
(Suppl. Figure 7c). Amplification of gapdh was used as a quantification control. Primer 
sequences are available on request. For rescue experiments, 150 pg of human C21orf2 RNA 
were co-injected with nek1 MO and embryos assessed for phenotypic features 3 dpf by light 
microscopy. RNA was generated using the mMessage Machine kit (Ambion) according to the 
manufacturer’s protocol. 
For whole-mount immunofluorescence analysis, embryos were dechorionated and fixed 
in 100% methanol overnight at í20°C. After rehydration, embryos were washed several times in 
PBST (0.5% Triton X-100/PBS) then blocked in 5% BSA for 1 hour and incubated with anti-
acetylated tubulin antibody (Sigma) overnight at 4°C followed by incubation with anti-mouse IgG 
488 secondary antibody (Sigma) and staining with DAPI. Embryos were flat mounted on glass 
slides in Citifluor (Citifluor Ltd) and immunofluorescence analysis was performed using a Zeiss 
confocal microscope. Image analysis was performed using ImageJ software. Images represent 
z-stack maximum intensity projections. Alcian Blue staining for cartilage visualization was 
performed after over-night incubation of dechorionated embryos in 100% methanol at í20°C 
using a 1% Alcian Blue 70% acidic ethanol solution. Histology of the eye was performed using 
paraffin embedded embryos and a standard H&E staining protocol. Transgenic zebrafish lines 
included rhodopsin:GFP (in house heterozygous out-cross of cu3Tg to TULP long fin wild-type) 
and smo mutant (in-house heterozygote x heterozygote cross of smob641/b641). 
 
Tandem affinity-purification and mass spectrometry 
HEK293T (human embryonic kidney) cells were transfected with constructs encoding either 
C21orf2, or NEK1, or SPATA7 fused to a strep-II tag/FLAG tag for tandem affinity purification 
(SF-TAP-tag) using polyethylenimine (PEI, PolySciences) as a transfection reagent. 48 hours 
after transfection the cells were lysed in lysis buffer containing 30mM Tris-HCl pH 7.4, 150 mM 
NaCl, 0.5% Nonidet-P40 (NP40), freshly supplemented with protease inhibitor cocktail (Roche 
Diagnostics, Mannheim, Germany), phosphatase inhibitor cocktail 2 (Sigma-Aldrich) and 
PhosphataseArrest III (GBiosciences) for 20 minutes at 4°C. The streptavidin- and FLAG-based 
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tandem affinity purification steps were performed as previously described47. 5% of the final elute 
was resolved by SDS-PAGE and analysed by silver staining according to standard protocols 
while the rest was subjected to protein precipitation with chloroform and methanol. Protein 
precipitates were subsequently subjected to mass spectrometry analysis and peptide 
identification as previously described47. 
 
Exogenous co-immunoprecipitation  
Plasmids expressing N-terminal SF-TAP-tagged SPATA7 and N-terminal SF-TAP-tagged NEK1 
were co-transfected with plasmids expressing HA-tagged wild-type C21orf2 or mutant 
constructs C21orf2-p.Arg73Pro or C21orf2-p.Leu224Pro in HEK293T cells. A plasmid 
expressing functionally unrelated HA-tagged LRR (leucine-rich repeat) domain of LRRK2 was 
used as a negative control. FLAG-NPHP4 and HA-RPGRIP1 (aa611-1286) were included as 
positive control as described previously47. 24 hrs post-transfection, cells were lysed on ice in 
lysis buffer (50 mM Tris-HCl [pH7.5], 150 mM NaCl, 1% NP-40) supplemented with complete 
protease inhibitor cocktail (Roche Diagnostics). Lysates were incubated with either Į-FLAG M2-
agarose from mouse (Sigma-Aldrich) or anti-HA affinity matrix (Roche) for 2-3 hrs at 4°C. After 
incubation, beads with bound protein complexes were washed in ice-cold lysis buffer. 
Subsequently, 4x NuPAGE sample buffer was added to the beads and heated for 10 minutes at 
70°C. Beads were precipitated by centrifugation, and supernatant was run on NuPAGE Novex 
4%-12% Bis-Tris SDS-PAGE gels. After blotting overnight at 4°C, blots were stained with either 
rabbit anti-FLAG (Sigma, 1:1000), mouse anti-FLAG (Sigma, 1:1000), rabbit anti-HA (Sigma, 
1:1000) or mouse anti-HA (Sigma, 1:1000). Goat anti-rabbit IRDye800 (Li-COR, 1:20,000) or 
goat anti-mouse IRDye800 (Li-COR, 1:20,000) were used as secondary antibodies. 
Fluorescence was analysed on a Li-COR Odyssey 2.1 infrared Scanner. Full unprocessed 
western blotting scans are shown in Suppl. Figure 8 with the regions used in main display 
items indicated by red frames. 
 
Endogenous co-immunoprecipitation from retinal extracts 
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Protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) were washed three times in 
extraction buffer (10mM HEPES [pH7.9], 10mM NaCl, 3mM MgCl2, freshly added 1mM DTT, 
1mM Na3VO4) supplemented with complete protease inhibitor cocktail (Roche) and then 
coupled to polyclonal anti-NEK1 (H3T1) or polyclonal anti-FLAG (Sigma, F7425) overnight at 
4°C. Coupled beads were washed three times in extraction buffer and incubated with fresh 
bovine retinal lysates overnight at 4°C. Retinas were homogenized by sonication on ice two 
times for 30 seconds in extraction buffer (10mM HEPES [pH7.9], 10mM NaCl, 3mM MgCl2, 
freshly added 1mM DTT, 1mM Na3VO4) supplemented with complete protease inhibitor cocktail 
(Roche). Beads were washed five times with extraction buffer, transferred to microspin columns 
(GE Healthcare) and washed three times in washing buffer (1xTBS, 0.12% NP-40, 
supplemented with complete protease inhibitors (Roche)). Then, neutralization buffer (1M 
Tris/HCl, [pH8.0]) was added. Eluates were retrieved by adding 3x elution buffer (200 mM 
glycine [pH2.5]) for 20 min. at 4°C and subjected to protein precipitation with chloroform and 
methanol. Protein precipitates were subsequently subjected to mass spectrometry analysis and 
peptide identification as previously described48. 
 
GST-pulldown from retinal extracts 
In order to produce GST fusion proteins, BL21-DE3 bacteria were transformed with either 
pDEST15-SPATA7, pDEST15-C21orf2 or pDEST15 alone. Protein expression was induced at 
28°C for 3 hours with 0.5 mM IPTG (Sigma-Aldrich) and harvested by centrifugation. 
Subsequently, cells were lysed with STE buffer (10 mM Tris-HCl, pH 8.0; 1 mM EDTA; and 150 
mM NaCl) supplemented with 10 mg/ml lysozyme, 0.5% Sarkosyl, 1% Triton X-100, and 
Complete protease inhibitor cocktail (Roche). Lysates were then incubated for 2 hours at 4°C 
with glutathione-sepharose 4B beads (Amersham Biosciences). After incubation, beads were 
washed with STE and TBSTD (TBS with 1% Triton X-100 and 2 mM DTT). The amount of GST 
fusion proteins bound to the beads was verified on a NuPAGE Novex 4%–12% Bis-Tris SDS-
PAGE gel by staining with SimplyBlue SafeStain (LifeTechnologies). Beads with bound GST-
fusion proteins were then incubated over-night with bovine retinal extracts at 4°C. After 
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overnight incubation, samples were washed three times with extraction buffer. Protein were 
eluted from beads in 4X NuPAGE sample buffer and heated for 10 minutes at 70°C. Beads 
were precipitated afterward by centrifugation. The supernatants were run on NuPAGE Novex 
4%-12% Bis-Tris SDS-PAGE gels, followed by immunoblotting overnight at 4°C and staining 
with rabbit polyclonal Į-NEK1 as primary antibody (H3T1; 1:1000) and goat anti-rabbit 
IRDye800 (LiCOR, 1:20,000) as secondary antibody. Fluorescence was analysed on a Li-COR 
Odyssey 2.1 infrared Scanner. Full unprocessed western blotting scans are shown in Suppl. 
Figure 8 with the regions used in main display items indicated by red frames. 
For mass spectrometry analysis of the GST pull down, beads were transferred to 
microspin columns (GE Healthcare), and washed 2 times with filtered TBS(1X). Eluates were 
retrieved by adding 300 µl of 100 mM reduced Glutathione (GSH) (Sigma-Aldrich) in 50mM Tris-
HCl [pH=8.0] and incubating overnight at 4°C on an Intelli mixer. Eluates were then subjected to 
protein precipitation with chloroform and methanol. Protein precipitates were subsequently 
subjected to mass spectrometry analysis and peptide identification as previously described48. 
 
Please refer to Supplementary Note for methodological details of the primary, secondary and 
tertiary screens. 
 
Please refer to Supplementary Note for methodological details of patient ascertainment and 
sample preparation, and genetic analyses including SNP genotyping arrays, linkage analysis, 
whole exome sequencing and Sanger sequencing. 
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SUPPLEMENTARY NOTE 
Whole genome siRNA-based reverse genetics screen for ciliogenesis 
Whole genome siRNA reagents: A Dharmacon mouse siGENOME siRNA library (Thermo 
Scientific) was used, plated in a standard 96-plate well format, consisting of 76269 
individual siRNA duplexes. Each gene was targeted by a pool of four duplexes per well, 
across 40 sub-library plates, 89 drug target sub-library plates, and 114 plates targeting the 
remaining genes in the mouse genome (the genome sub-library). After the removal of 38 
duplicated reagents, the entire library targeted a total of 19059 unique Entrez RefSeq 
(B37.1) genes across 243 plates, of which 18960 also targeted a unique Ensembl (r69) 
mouse gene. Library plates contained 80 targets per plate across columns 2-11. 
Lyophilised siRNA was re-constituted with 1X RNA buffer (Thermo Scientific) to a 
FRQFHQWUDWLRQ RI ȝ0 XVLQJ D )OXLG-X XRD-384 dispenser, followed by 90 minutes of 
agitation on a rotary shaker. Reconstituted siRNA plates were stored at -80oC. Thawed 
siRNAs were directly aliquoted into 96-well assay plates (PerkinElmer View Plates) using 
an Agilent Bravo liquid handling platform. Eight different control siRNAs (siGENOME, 
Thermo Scientific) DW ȝ0 ZHUH DGGHG WR SODWHV XVLQJ D 6WDU-pet-E 8-channel electronic 
pipette (in duplicate to columns 1 and 12) for a 50nM final concentration of poled siRNAs. 
Each 96-well plate contained six positive assay controls (siRNA pools for Mks1, Rpgrip1l 
and Ift88 each in duplicate; Suppl. Table 10) that had significant and reproducible inhibitory 
effects on ciliogenesis, and one positive transfection control (duplicate siRNA pool for Plk1, 
a gene essential for cell growth and proliferation) that significantly affected cell number 
(Figure 1c). We also included eight negative control siRNAs (two non-targeting or 
³VFUDPEOHG´VL51$VDQVL51$WDUJHWHGDJDLQVWKXPDQPRWLOLQUHFHSWRUMLNR) that has no 
sequence orthologue in the mouse genome (Suppl. Table 10), and a mock-transfection 
control. These controls had no significant effect on the percentage of cells with a single 
cilium (Figure 1c,d), as previously reported1. The strictly standardised mean difference 
(SSMD)2,3 of the percentage of cells with a single cilium in Mks1, Ift88 and Rpgrip1l 
knockdowns, compared to all negative controls was consistently >1.5, reflecting the 
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suitability of these siRNAs as positive controls for effects on ciliogenesis (data not shown). 
Sequences of control siRNA duplexes are given in Suppl. Table 10. For the validation 
screen unpooled duplexes of Dharmacon ON-TARGET-PLUS siRNAs were used at a final 
concentration of 12.5nM. 
Whole genome siRNA transfections: Reverse siRNA transfections were set up in 
EDWFKHVRISODWHVȝOVL51$ZHUe added per well to optical-bottomed 96-well Perkin 
(OPHU 9LHZ 3ODWHV IROORZHG E\ ȝO /LSRIHFWDPLQH 51$L0$; WUDQVIHFWLRQ UHDJHQW
(LifeTechnologies VXVSHQGHG LQ ȝO 2SWL-MEM serum free media (Invitrogen) using a 
FluidX XRD-384 dispenser at high speed (300rpm). Plates were gently mixed on a rotary 
VKDNHUDWURRPWHPSHUDWXUHIRUDPLQLPXPRIPLQXWHVȝOP,0&'FHOOVDWDGHQVLW\
of 105 cells per ml in Opti-MEM, in a uniform suspension maintained by constant magnetic 
stirring, were added per well to plates using an XRD-384 FluidX dispenser at high speed. 
To minimize edge effects, cells and transfection complexes were left to rest in a laminar 
flow hood for 1 hour at room temperature before returning to a 37oC 5% CO2 incubator 
without further changes of media in wells. Cells were assayed after 72 hours, at which time 
they formed a uniform monolayer of 95-100% confluency. This confluency was optimal for 
the detection of cilia at the same single focal plane in every well, since over-confluent cells 
grew in multiple layers. The proportion of ciliated cells was consistently above 60% which is 
comparable with previous reports1. Hits confirmed in the secondary screen were validated 
in scaled-up format following a previously described protocol1. 
High-throughput liquid handling: Plates were processed for immunofluorescent staining 
in batches of 20. 72 hours after transfection, media was removed from plates by inverting 
the plate and blotting on clean paper towels to remove excess liquid. Cells were washed 
WKUHH WLPHVZLWKȝO3%6XVLQJ WZR;5'-384 FluidX dispensers working in parallel on 
slow speed (100rpm), dispensing to the left side of the well to minimise disturbance of cells. 
After fixation, all cell washes were performed at medium speed (150rpm). After incubation 
ZLWK SULPDU\ DQWLERG\ FHOOV ZHUH ZDVKHG RQFH XVLQJ ȝO 3%6 RQ D ;5'-384 FluidX 
dispenser and three times on a Biotek ELx405 Select CW plate-washer with a Biostack 
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automated plate stacker that dispensed against the left side of the well. After incubation 
ZLWKVHFRQGDU\DQWLERG\DQGVWDLQVFHOOVZHUHZDVKHGRQFHXVLQJȝO3%6RQD;5'-
384 FluidX dispenser and six times on a Biotek ELx405 Select CW plate-washer with a 
Biostack automated plate stacker. Plates wHUHVWRUHGZLWKȝO3%6SHUZHOODWoC for up 
to 1 week before imaging. 
Fixation: Optimisation experiments proved that ice-cold methanol fixation gave much better 
resolution of cilia staining and lower background compared to other fixation methods in 
mIMCD3 cells. The success of methanol fixation when optimized for high-throughput 
depended on maintaining the methanol temperature on dry ice, pre-chilling the dispenser 
tubing prior to dispense, and placing plates into a -20oC freezer for exactly 5 minutes. Cells 
were fixed for exactly 5 min. using ice-cold methanol. Methanol was removed from a -20oC 
freezer and kept on dry ice whilst passing through the dispenser tubing (which was placed 
between two frozen ice blocks) for 1 minute to ensure the temperature of methanol being 
GLVSHQVHGLQWRSODWHVZDVPDLQWDLQHGȝOLFHFROGPHWKDQROZDVGLVSHQVHGWRWKHOHIWVLGH
of each well using FluidX XRD-384 dispenser on slow speed (100rpm), taking ca. 30s to 
dispense the methanol per plate. Plates were then placed in a -20oC freezer on top of 
frozen ice blocks for exactly 5 min. After fixation, each plate was removed from the freezer, 
inverted and blotted to remove methanol. A second pre-primed dispenser was used to 
GLVSHQVHȝO3%6LQWRHDFKZHOORIWKHSODWH7KHVDme speeds and volumes were used 
on the two dispensers to ensure that each plate was fixed in methanol for the same length 
of time. 
Antibodies and staining reagents for immunofluorescent staining: DAPI was used with 
the far-red RNA stain TOTO3 (LifeTechnologies) to determine cell, cytoplasm and nuclear 
ERXQGDULHV&LOLDZHUHGHWHFWHGZLWKDPRXVHPRQRFORQDODQWLERG\DJDLQVWDFHW\ODWHGĮ-
tubulin, a cilia marker with specificity for the entire length of the primary ciliary axoneme and 
low background staining (clone 6-11 B-1, catalogue number T6793, lot no 070M4755, 
Sigma-Aldrich) and an Alexa Fluor 488-conjugated secondary antibody (LifeTechnologies). 
Optimization experiments in pilot screens showed that separate primary and secondary 
4 
antibody binding steps were essential for high-quality cilia staining. Plates were blocked 
ZLWK ȝO  QRQ-fat milk powder/PBS (w/v) previously clarified of particulates by 
centrifugation at 3000 x g for 5 min. All antibodies and stains were diluted in blocking 
solution and clarified by centrifugation at 12,000 x g for 5 min. at room temperature. Primary 
antibody (anti-acetylated alpha tubulin) was diluted x1000 and cells were incubated with 
ȝO DQWLERG\ VROXWLRQ SHU ZHOO IRU RQH KRXU DW URRP WHPSHUDWXUH 6HFRQGDU\ DQWLERG\
(x2000 dilution), and DAPI and TOTO-3 (both x5000 dilutions) were incubated for one hour 
at room temperature in the dark. 
High-throughput high content imaging: Plates were processed using the PerkinElmer 
Operetta high-content wide-field fluorescence imaging system, coupled to Harmony 
software. Plates were automatically loaded onto the Operetta using a PerkinElmer Plate 
Handler II robotic arm, operated through Plateworks software. Plates were bar-coded with 
specific plate information, and barcodes were read by a SICK barcode reader before 
loading onto the Operetta. Wells were imaged using a x20 objective lens, detecting three 
colours in three separate focal planes to ensure the best resolution was obtained for each 
colour. The bottom of each well was detected automatically by the Operetta infra-red 
focusing LED, and focal planes of detection for each colour were calculated relative to this 
value. DAPI emission was detected for 60ms, ȝPabove the calculated bottom of the well. 
TOTO3 emission was detected for 500ms, ȝP DERYH WKH '$3, SODQH DQG $OH[D )OXRU
488nm HPLVVLRQZDVGHWHFWHGIRUPVȝPDERYH the DAPI plane (Figure 1a). Six fields 
RIYLHZHDFK[ȝPZHUHLPDJHGSHUZHOOZLWKDQLGHQWLFDOSDWWHUQRIILHOGVLQHYHU\
well away from the dispense area), with an approximate total of 4000 cells detected and 
analysed per well. 
Image analysis: Modified PerkinElmer image analysis algorithms were used throughout. 
Cilia in assay plates remained vertical and therefore appeared as discrete dots 1-ȝP LQ
diameter (Figure 1b). This enabled us to develop highly efficient cilia detection protocols 
based on pre-GHVLJQHG3HUNLQ(OPHUµILQGVSRWV¶DOJRULWKPV&LOLDZHUHFRQVLVWHQWO\LGHQWLILHG
DWD IRFDOSODQHDERYH WKHDSLFDOFHOOVXUIDFHȝPDERYH WKH IRFDOSODQHRI WKe nucleus. 
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Cells were stained with DAPI and TOTO-3, allowing accurate segmentation of cells (Figure 
1a). This methodology highly improves specificity for high-throughput cilia detection when 
compared to previously reported HTS cilia assays4. Nuclei were detected as blue (DAPI) 
IOXRUHVFHQW UHJLRQV !ȝP2, with contrast >0.10. Cytoplasm was detected as far-red 
(TOTO3) fluorescent regions around nuclei. Border objects were excluded so that only 
whole cells were analysed. Cilia on whole cells were detected usinJDPRGLILHGµILQGVSRWV¶
algorithm, identifying green (Alexa Fluor 488) fluorescent spots with radius <3.8 pixels, 
contrast >0.1, spot-to-region intensity >1.3 with a distance from all neighbouring spots >5.6 
pixels. Any cells with more than one cilium in the cell area were excluded from analysis. 
Key output parameters were number of whole cells, and percentage of whole cells with a 
single cilium. Additional output parameters included number of whole cells with two or more 
cilia and mean cilium intensity, which could be used as an indicator of cilium length. 
Screen quality control and statistical analyses: The strictly standardised mean 
difference (SSMD) of the percentage of cells with a single cilium in Mks1, Ift88 and Rpgrip1l 
knockdowns, compared to all negative controls was consistently >1.5 reflecting the 
suitability of these siRNAs as positive controls for effects on ciliation, and the consistency 
and quality of the screen. For cilia length measurements, normal distribution of data was 
confirmed using the Kolmogorov-Smirnov test (GraphPad Software). Pair-wise comparisons 
were analysed with Student's two-tailed t-test or one-way analysis of variance (ANOVA) 
using InStat (GraphPad Software). Significance of pair-wise comparisons indicated as: ns 
not significant, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. Results reported are from at 
least three independent biological replicates. 
GESS analysis: To further control for false positive effects in the screen, we performed 
GESS analysis5 to identify seed sequences which were enriched in our hit list and thus 
likely to be due to non-specific microRNA-like effects. We identified a total of 79 genes in 
the whole genome library (Suppl. Table 1) and 14 hits from the primary screen (Suppl. 
Table 2) that had enriched seed sequences. These were excluded from further analysis. 
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Cell line characterisation: To control for false positive effects in the screen, we performed 
extensive characterisation of mIMCD3 cells, to study whole genome copy number and 
whole transcriptome expression level. 
Array CGH: Array CGH analysis identified 5274 genes with abnormal copy number in 
mIMCD3 cells, including three biallelic losses. The three genes with biallelic losses were 
excluded from analysis. None of the 1940 siRNA hits in the ciliogenesis screen had biallelic 
losses, but 711 were found to have abnormal copy number. No results were filtered or 
weighted on the basis of this data, but it may be useful to do so in future analyses. Other 
possible sources of false positive and negative hits are sequence-independent off-target 
effects due to siRNA competition with/saturation of endogenous RNAi, especially if the cell 
line used is under-expressing rate-limiting components of RNAi: exportin-5, TRBP, Dicer, 
Ago1-4. To control for these effects we confirmed normal copy number of rate-limiting 
components of RNAi in mIMCD3 cells by array CGH. Xpo5 had normal copy number, 
Tarbp2 +1 gain, Dicer1 +1 gain, Eif2c1 no info but very close to Eif2c3 and Eif2c4 on 
mouse chromosome 4, (these both have normal copy number therefore Eif2c1 likely to 
have normal copy number), Eif2c2 +1 gain, Eif2c3,4 normal. Importantly, there were no 
genomic losses in these crucial parts of RNAi machinery. 
BLASTN alignment: We undertook BLASTN alignment analysis of the entire Dharmacon 
mouse siGENOME siRNA library to identify siRNAs with sequence-specific off-target effects 
and pools of siRNAs that did not target all transcripts of a gene. Of the 19059 unique Entrez 
RefSeq genes in the entire library, 832 were found to have off-target mappings. These 
genes were excluded from our analysis, including n=133/2174 hits from the primary screen 
(Suppl. Table 2). Potential false negative results may arise from incomplete targeting of 
mRNAs by siRNAs in the Dharmacon siGENOME siRNA pools. BLASTN alignments of 
siRNA sequences identified 2031 siRNAs that only partially target their target gene, with at 
least one non-targeted transcript per gene (Suppl. Table 1). These siRNAs were not 
excluded from our screen analysis, but weighting could be applied to effects seen in these 
knockdowns to account for the only partial targeting of genes. BLASTN analysis confirmed 
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that the Plk1, Mks1, Rpgrip1l and Ift88 siRNA pools targeted every Ensembl annotated and 
protein coding alternative transcript of the target genes, with the exception of one 
incomplete Rpgrip1l transcript (ENSMUST00000132757) encoding a predicted 78 amino 
acid isoform of the protein. 
DAVID analysis: To minimize false negative results from the primary screen list, we 
performed functional annotation clustering and enrichment analysis for either BioCarta and 
KEGG pathways or gene ontology (GO) terms using DAVID6,7. We selected a total of 373 
hits that had human orthologues and were part of a pathway that was significantly enriched 
based on a Benjamini-Hochberg adjusted p value <0.05. Based on functional categorization 
and relevant literature information, we prioritized enriched components of the spliceosome, 
the proteasome and the ubiquitin-proteasome system (UPS). We excluded hits that could 
be due to non-specific secondary effects (e.g. associated with the ribosome, RNA 
polymerase, purine and pyrimidine biosynthesis), leaving a final number of 40 hits 
(secondary screen 1, Suppl. Table 3). The n=154 hits that passed the zcell> zcell cutoff filter 
(secondary screen 2, Suppl. Table 3) were also analysed in DAVID, and these identified 
enrichment of GPCRs, the non-motile primary cilium and the photoreceptor outer segment. 
Additional unvalidated data-sets: We also imaged other cellular phenotypes during data 
acquisition for the primary screen. These comprised modified PerkinElmer image analysis 
algorithms (available on request) to measure cilia intensity and pyknotic nuclear 
morphology to enable the assessment of cilia length and apoptosis. In brief, cilia intensity 
measurements used the PRGLILHG µILQGVSRWV¶DOJRULWKP described above. Apoptotic nuclei 
were detected as regions of DAPI staining with area >15ȝP2 and <50ȝP2, mean intensity 
>2000, and roundness <0.5. We include these numerical features expressed as robust z 
scores (Suppl. Table 1) to enable interrogation and further annotation of our screen data-
set in future validation screens. We also note that n=780/1829 of the total hits from the 
primary screen also have an effect on ciliogenesis (zcilia) that is significantly greater (z>-2) 
than any effect on cell number (zcell) (Suppl. Table 11&RPSDULVRQRIWKLV³ORQJOLVW´RI
genes against known ciliary components (the SYSCILIA Gold Standard8), revealed a 
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significant 2.3-fold enrichment of known ciliary components (p = 1.0x10-5 hypergeometric 
test, observed 29, expected 12.6). 7KH ³ORQJ OLVW´ WKHUHIRUH DOVR FRPSULVHV DQ DGGLWLRQDO
resource for future validation of genes mediating ciliary processes or ciliopathy candidate 
genes. 
 
Secondary siRNA screens in mIMCD3 and hTERT-RPE1 cells 
Secondary validation screens were performed in mIMCD3 and hTERT-RPE1 cells to 
validate the hits from the primary siRNA screen. Screening in mIMCD3 cells consisted of 
duplicate siRNA knockdowns, using four unpooled siRNA duplexes with a different 
chemistry (Dharmacon ON-TARGET PLUS) from the primary screen (Dharmacon 
siGENOME) for a total of 194 genes (Suppl. Table 3), and assaying for effects on 
ciliogenesis defects using the same platform and analysis as the primary screen. The 
complete dataset for this screen is shown in Suppl. Table 3 and consists of 68 genes. 
 Screening in hTERT-RPE1 cells consisted of single siRNA knockdowns for all 57 
UPS hits identified in the primary siRNA screen using Silencer Select siRNA duplexes 
(LifeTechnologies). For transfection, siRNAs (15 nM final concentration) were plated in 
black MW96 plates (BD Falcon), Lipofectamine RNAiMax (LifeTechnologies) and Opti-MEM 
(LifeTechnologies) were added to the duplexes and incubated for 10-20 minutes according 
to manufacturer¶VSURWRFRO WRDOORZWKHIRUPDWLRQRI WUDQVIHFWLRQFRPSOH[HVK7(57-RPE1 
cells (2.5x104 cells per well) were then plated in the MW96 plates. Per plate, three non-
targeting duplexes and three PLK1 duplexes were included as negative controls or 
transfection controls, respectively. After 24 hours of transfection, cells were serum-starved 
'0(0+DP¶V)ZLWK)&6 WR LQGXFHFLOLRJHQHVLV$IWHUKRXUVRI WUDQVIHFWLRQ
cells were washed with PBS, and fixed with 2% paraformaldehyde for 20 min. After fixation, 
cells were washed briefly in PBS, permeabilized in 1% Triton-X/PBS for 5 minutes and 
blocked in 2% BSA/PBS for 30 minutes. After blocking, cells were stained with anti-
acetylated tubulin (Sigma, clone 6-11B-1; 1:1000) and anti-RPGRIP1L9 (SNC040; 1:500) 
for one hour. Then, cells were washed in PBS (3x5 min) and stained with goat anti-mouse 
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Alexa Fluor 488 (LifeTechnologies; 1:500), goat anti-guinea pig Alexa Fluor 568 
(LifeTechnologies; 1:500) and DAPI (LifeTechnologies; 1:8000) for 45 minutes. Finally, cells 
ZHUH ZDVKHG LQ 3%6 [ PLQ DQG VWRUHG LQ 3%6 DW Û& SULRU WR PLFURVFRS\ DQDO\VLV
Microscopy analysis of this screen was performed using a Leica DMI-6000B high-content 
microscope. Multiple focal plane images were captured from four regions per well for each 
channel. Data was analyzed automatically to define the number of nuclei, number of cilia 
and cilia length using FIJI-based plug-ins (FindFocus and CiliaMeasurement plug-ins) 
which were developed specifically for these experimental conditions. First, for each image 
the focal plane for analysis was determined using the FindFocus plug-in. Second, the 
CiliaMeasurement plug-in was applied to determine the number of nuclei and cilia, and 
length of cilia. Edged objects of each image were excluded from the analysis. Data for each 
image were then exported to Excel and analyzed for significant effect on ciliated cell per 
well (sum of four images), using robust z scores for cilia length (zcilia length) and for % cells 
with a single cilium (zcilia). The results from this screen are shown in Suppl. Table 4. 
 
Tertiary siRNA screen in hTERT-RPE1 cells 
In the tertiary screen, we re-screened the n=68 gene hits validated in the secondary screen 
using pooled Dharmacon ON-TARGET PLUS siRNAs in hTERT-RPE1. Transfection and 
image analysis methods were the same as for the validation siRNA screen in hTERT-
RPE1, listing robust z scores listed for cilia length (zcilia length) and for % cells with a single 
cilium (zcilia). The complete datasets for this screen are shown in Suppl. Table 3. 
 
Patient ascertainment and sample preparation 
All samples used in this study were obtained with informed consent according to the 
protocols approved by the ethical committees of the Institute of Child Health/Great Ormond 
Street Hospital (REC ref. no. 08/H0713/82), South Yorkshire Research Ethics Committee 
(11/H1310/1), King Faisal Hospital, Saudi Arabia (RAC# 2070 023), and the University of 
Washington, Seattle WA (Protocol #28853). Inclusion criteria for Joubert syndrome were: 
10 
(1) molar tooth sign or cerebellar vermis hypoplasia and superior cerebellar dysplasia on 
brain imaging, and (2) clinical findings consistent with JBTS (cognitive impairment, 
hypotonia and ataxia). Imaging findings for PIBF1-mutated individuals ranged from the 
classic molar tooth sign to moderate vermis hypoplasia with mildly thick superior cerebellar 
peduncles and characteristic superior cerebellar dysplasia (Figure 6a-c, Suppl. Figure 3, 
Suppl. Table 6). One individual had peri-Sylvian polymicrogyria, and several had prominent 
perivascular spaces. All individuals for whom information was available had ataxia and 
developmental delay, ranging from mild to moderate (Suppl. Table 7). Three had 
oculomotor apraxia, and abnormal breathing pattern was noted in only one. None of the 
affected individuals had other features commonly associated with JBTS including 
polydactyly, coloboma, retinal dystrophy, nephronophthisis and liver fibrosis. 
Inclusion criteria into the UCL Whole Exome Study was clinical diagnosis of Jeune 
syndrome based on typical radiological features such as short ribs, narrow thorax, 
handlebar clavicles, trident acetabulum, cone shaped epiphyses and other typical clinical 
symptoms such as renal, liver and retinal involvement as previously described in the 
literature. Inclusion criteria for primary ophthalmological patients was clinical diagnosis of 
retinal degeneration with assignment to a specific clinical subtype (rod-cone dystrophy) 
based on clinical and, in selected cases, electrophysiological assessment. Genomic DNA 
was isolated from peripheral venous blood or saliva by standard salt extraction. Total RNA 
was extracted from muscle tissue with the TRIzol method (LifeTechnologies). 
All JBTS patients were tested for linkage to known JBTS disease genes, or had 
mutations excluded by direct Sanger sequencing, MIPS or WES. Founder pathogenic 
variants in the two known Hutterite JBTS genes TMEM23710 and CSPP111,12 were excluded 
from Hutterites. 
 
SNP genotyping arrays and linkage analysis 
WES and homozygosity mapping were used in combination to identify the rare homozygous 
missense variant in JBTS individual H1-3, which was surrounded by a 15.6 MB region of 
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absence of heterozygosity on chromosome 13. For family GC4693, all five affected siblings 
and the unaffected mother were genotyped using a 50k Xba SNP Array (Affymetrix Inc.) 
DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V SURWRFRO $V WKHUH ZDV QR VNHOHWDO QRU UHWLQDO GLVHDVH LQ
parents or other relatives, data were analyzed assuming an autosomal recessive model in 
which all five siblings would share identical genotypes around the causative gene. Linkage 
was excluded for regions surrounding known candidate retinal dystrophy genes. Seven 
regions over 1Mb were consistent with linkage. There were no significant regions of shared 
autozygosity. 
 
Genetic analyses including whole exome sequencing 
DNA isolation and exome sequencing for samples CR-F024.1 and F2.1 have been 
previously published13. For all other individuals, DNA was isolated from human EDTA blood 
saPSOHV XVLQJ *HQWUD 3XUHJHQH %ORRG NLW 4LDJHQ DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V
SURWRFRO ȝJ RI '1$ ZHUH XVHG IRU ZKROH H[RPH VHTXHQFLQJ DQG SURFHVVHG XVLQJ D
standard protocol as previously described14. Samples UCL111.1 and UCL111.2 were 
processed as part of the UK10K project (www.uk10k.org) using the Agilent V2 Sure Select 
50 MB whole exome kit. Sample UCL78.1 was sequenced (Axeq Technologies) using 
1LPEOJHQ9ZKROHH[RPHNLW'1$VDPSOHVZLWKD µ8&/¶SUHIL[ZHUHDQDO\VHGIRU&19V
using the ExomeDepth Program15. In brief, 50 bp reads were aligned to hg19 reference 
genome and followed by variant calling (Lifescope V.2.1 software). Variants from all 
samples were annotated and prioritised to identify pathogenic mutations as previously 
described14,16. Inclusion criteria for variants consisted of being covered by at least 10 
sequence reads wherein the variant must be present in at least 20% of the reads (variants 
detected in 20%±80% of the sequence reads were considered heterozygous). Variants 
annotated in dbSNP132, the 1000 Genomes project, the Seattle exome database 
(http://www.evs.gs.washington.edu) or our UCL in-house database with a minor allele 
frequency (MAF) >0.5%, were removed as were all variants outside of known coding 
genetic sequencing and up to 20 bp intronic around exons. 
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For the siblings UCL111.1 and UCL111.2, we further filtered for variants present in 
both individuals using Exome Variants Analysis and Reporting (EVAR) software 
(http://www.exome.info). An autosomal recessive inheritance model was applied for gene 
identification, with known JATD and SRPS genes manually visually analysed (Integrative 
Genomics Viewer; http://www.broadinstitute.org/igv/). 
DNA from subject GC4693.1 was analyzed by WES, using the Illumina TruSeq 
Exome Enrichment Kit and run on an Illumina HiSeq2000 sequencer. Reads were aligned 
to the human reference sequence (UCSC Genome Browser hg19) with Novoalign 
(Novocraft) version 2.05. The ANNOVAR tool (OpenBioinformatics) was used for 
annotating SNPs and small indels. Candidate pathogenic variants were validated and 
assessed for familial segregation by Sanger sequencing. 
The Hutterite variant p.Asp637Ala in PIBF1 is predicted to be deleterious by 
Polyphen2 (0.999/0.996) but tolerated by SIFT, whilst p.Arg405Gln is predicted deleterious 
by Polyphen2 (1.0/0.996) and damaging by SIFT17. The overall minor allele frequency for 
p.Arg405Gln in all ethnic groups for ExAC datasets is 1.416% (rs17089782; 1720/122044 
alleles, 79 homozygous genotypes reported). The p.Asp637Ala variant was absent in all 
ESP or ExAC datasets, however in 550 North American Hutterite individuals from all three 
Leut groups it was identified as heterozygous in 23 and homozygous in one 57 year old 
woman for whom no other medical information was available. In whole genome sequence 
data for a cohort of 98 Schmiedeleut Hutterite individuals, the variant was found to be 
heterozygous in 7, and homozygous in one 8 year old boy who scored as 10-25 percentile 
RQWKH5DYHQ¶V3URJUHVVLYHMatrices18 and had night-time incontinence but was not noted 
to have other medical issues (no further information available). Using SNP genotyping data 
to impute the missense variant genotype in a total cohort of 1401 Schmiedeleut Hutterite 
individuals identified no additional individuals homozygous for the variant, despite an 
estimated carrier frequency of 7%19.  
Targeted molecular inversion probe sequencing (MIPS) of PIBF1 in a cohort of 
affected individuals from 353 additional families identified single heterozygous truncating 
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PIBF1 variants in five additional affected individuals. WES also identified two predicted 
deleterious heterozygous PIBF1 variants (c.1669delC, p.Leu557Phefs*18 and c.673-
?_1322+?del, for affected individual UW155-3 and for those in family MTI-121; Suppl. 
Table 5) that segregated with disease (Suppl. Figure 2d-e). Both deleterious variants were 
in combination with c.1214G>A p.Arg405Gln. No other heterozygous variants in PIBF1 
(including SNVs and CNVs) were identified in these individuals, suggesting that the 
combination of a unique truncating allele and a more common variant (c.1214G>A 
p.Arg405Gln) may be pathogenic20. Although exogenous expression of human wild-type 
PIBF1 rescued ciliogenesis in mIMCD3 cells following siRNA knockdown of endogenous 
Pibf1, expression of PIBF1 containing either p.Asp637Ala or p.Arg405Gln was unable to 
rescue normal ciliogenesis suggesting that they are pathogenic missense mutations 
(Suppl. Figure 4). 
The C21orf2 p.Pro73Arg minor allele frequency in all ethnic groups for ExAC 
datasets is 0.03304% (rs140451304; 37/111976 alleles, no homozygous genotype 
reported). Although this variant is predicted benign by Polyphen2 and Mutationtaster, amino 
acid residue Pro73 is highly conserved in a leucine-rich repeat (LRR) domain (Figure 6m) 
and the substitution is non-conservative (Grantham score is >100). The p.Leu224Pro 
mutation is predicted damaging by Polyphen2 and Mutationtaster. No material was 
available to confirm the effect of the c.96+6T>A variant on splicing in individual UCL78.1 
(Suppl. Figure 5f). However, Alamut software predicted that the c.96+6T>A variant caused 
a significant decrease in splicing probability and loss of a predicted SRp55 splicing 
enhancer binding site (Suppl. Figure 5f). 
An affected sibling of UCL-111.1 and UCL111.2 carried the same mutations in 
C21orf2 and had cone-rod dystrophy (Figure 6k) but with no signs of skeletal features of 
Jeune syndrome. This is consistent with a previous report that C21orf2 is a candidate gene 
for non-syndromic retinal degeneration (cone-rod dystrophy), with homozygous variants 
found in two consanguineous families of Arabic origin13. The two individuals reported in 
Abu-Safieh et al. (2013)13 were therefore re-assessed as adults for any skeletal 
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involvement. This revealed that individual CR-F024.1 (c.103delA, p.Ile35Phefs*10; Suppl. 
Figure 5c) in addition to cone-rod dystrophy (Figure 6l) has a narrow thorax and very short 
stature but no cone shaped epiphyses (Figure 6I,j, Suppl. Table 7). The second individual 
F2.1 (c.545+1C>T, p.Ala181Glnfs*6 Suppl. Figure 6e-f), has no skeletal abnormalities 
(Suppl. Table 7). However, since individual F2.1 was examined at 4 years of age and early 
but mild skeletal Jeune syndrome phenotypes may regress in later life14,16,21,22, it is possible 
that additional mild signs of Jeune syndrome were present neonatally. Further screening of 
C21orf2 identified, in a non-consanguineous individual of northern European origin 
(GC4693.1), a homozygous missense change shared with the UCL-111 family 
(p.Arg73Pro). GC4693.1 has cone-rod dystrophy, severe scoliosis and hip dysplasia 
(Suppl. Table 7). The same homozygous mutation was found in his four younger siblings 
who are all affected with a similar phenotype but more severe retinal degeneration, and 
Sanger sequencing confirmed that this variant segregates with the disease (Suppl. Figure 
5b). These findings indicate that mutations in C21orf2 (Figure 6m) cause both syndromic 
and non-syndromic forms of retinal dystrophy, with a variable spectrum of skeletal 
involvement. 
 
Sanger sequencing 
Mutation verification was undertaken by performing PCR reactions under standard 
conditions and Sanger sequencing was performed at Source Bioscience, Cambridge, UK 
(PCR protocol and primer sequences are available on request). Sanger sequencing 
confirmed segregation of variant with phenotype in all cases in Schmiedeleut and Leherleut 
Hutterite JBTS families H2, H3 and H4 and in individual UW155-3. 
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